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Reactive oxygen species (ROS) are highly reactive signalling molecules, produced 
naturally as by-products of oxidative metabolism, which can lead to a state of oxidative 
stress when in excess. ROS can be cytotoxic to neurons and high levels are linked to 
many neurodegenerative diseases. Neurons counter excessive ROS in part through 
transcriptional upregulation of antioxidant enzymes. Class IIa histone deacetylases 
(HDACs) are transcriptional co-regulators that can either repress or activate gene 
transcription. They repress MADS box (MEF2) transcription factor mediated gene 
expression by promoting chromatin compaction and activate forkhead (FOXO) 
transcription factors through deacetylation. Class IIa HDACs are regulated by signal-
dependent nucleocytoplasmic shuttling whereby increased neuronal firing triggers their 
nuclear export. Whilst these HDACs are linked to both neuroprotection and 
neurodegeneration, little is known about their activity and regulation under oxidative 
stress.  
This thesis aimed to investigate class IIa HDAC regulation under oxidative stress 
conditions. Oxidative stress was imposed using either diethyl maleate (DEM) to deplete 
cellular glutathione levels or paraquat which affects the mitochondrial electron transport 
chain. Work here shows that both HDAC4 and 5 translocate to the nucleus of rat cortical 
neurons under DEM-induced oxidative stress, whereas paraquat has different effects on 
HDAC4/5 localisation. Furthermore, HDAC5 showed a dephosphorylation, essential for 
its nuclear import. Putative FOXO target genes Tpm2 and Spp1 were induced in neurons 
during moderate oxidative stress, suggesting that ROS-induced nuclear imports of 
HDAC4/5 promote deacetylation and activation of FOXOs. Transgenic flies expressing 
human HDAC5 or a constitutively nuclear HDAC5 mutant, raised on DEM food, displayed 
strong increases in Drosophila Gadd45 gene mRNA levels, and in silico approaches 
revealed Gadd45 as a putative FOXO target. Moreover, transgenic flies showed a 
possible translocation of expressed HDAC5-GFP to the nucleus of Drosophila neuronal 
cells. Therefore, the proposed mechanism occurring during low oxidative stress may be 
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Reactive oxygen species (ROS) are unstable, highly reactive chemical species produced 
as natural by-products of oxidative metabolism in all eukaryotic cells. Neurons are shown 
to be particularly vulnerable to ROS, partly due to their postmitotic nature and high 
metabolic activity. At low levels, ROS play essential roles in neuronal homeostasis and 
signalling including in the regulation of synaptic plasticity (Oswald et al., 2018). However, 
ROS can accumulate when cellular antioxidant capacity is impaired or overwhelmed, 
leading to a state of oxidative stress (Liu et al., 2018). Neurons can counter ROS in part 
through transcriptional regulation of antioxidant enzymes (Qiu et al., 2020). This 
introduction summarises our current understanding of some of these antioxidant 
mechanisms in neurons.  
 
1.1. Reactive oxygen species and the oxidative stress phenomenon 
 
Reactive oxygen species can oxidise many cellular molecules due to their highly reactive 
and cytotoxic nature. Examples of ROS include hydrogen peroxide (H2O2), superoxide 
(O2-) and hydroxyl radicals (OH-). Neuronal ROS are generated endogenously by 
neurons during mitochondrial ATP generation (Figure 1) and subsequent ‘leakage’ of the 
electron transport chain (Oka et al., 2009). Energy created through redox reactions using 
enzymes of the electron transport chain generates an electrochemical proton gradient 
across the inner mitochondrial membrane, which provides the energy required for ATP 
synthesis (Zhao et al., 2019). 
Electrons are passed through complexes I to IV on the inner mitochondrial membrane 
(IMM), and a series of redox reactions provide energy for proton pumping which sets up 
the electrochemical proton gradient (Figure 1). Complex IV normally reduces oxygen to 
water, but occasionally electrons passing through complexes I and III react with oxygen 
to generate superoxide. These ROS ‘leak’ out of the electron transport chain and 
contribute to cellular ROS levels. Elevated levels of ROS themselves can also cause 
more ROS release from mitochondria (Zorov et al., 2014), a phenomenon known as ROS 


























Figure 1: Representation of ROS sources including leakage of the electron transport chain in 
mitochondria and subsequent damage caused by oxidative stress. Other sources of ROS include 
metabolic processes, NADPH oxidases and ROS induced ROS release (RIRR) from the 
mitochondria. Oxidations to cellular components can lead to damages such as lipid peroxidation 
leading to membrane degradation, protein oxidation causing enzyme inactivation and changes in 
protein function, folding and interactions as well as DNA fragmentation.  
The unpaired electrons which classify these ROS species can result in oxidation (Figure 
1) and significant damage to DNA, lipids and proteins (Wiseman & Halliwell, 1996). This 
process has been implicated in aging, cancer and many neurodegenerative diseases, 
where it can contribute to functional decline in Alzheimer’s Disease (AD) and Parkinson’s 
Disease (PD) amongst others (Gandhi & Abramov, 2012). Specifically, oxidative stress 
can become deleterious to normal brain functioning. The human brain is said to make up 
around 20% of the body’s total basal oxygen consumption (Magistretti & Allaman, 2015) 
requiring high rates of mitochondrial ATP synthesis, oxidative metabolic activity, and 
ROS production (Lee et al., 2020). The brain also contains a high concentration of 
polyunsaturated fatty acids which can become targets of free radical induced lipid 
peroxidation (Burnside & Hardingham, 2017). Additionally, DNA fragmentation as a 
result of oxidative stress can lead to aberrant gene expression and even cell death (Choi, 
1993), and the disruption of protein functioning via oxidation can inhibit the action of 
receptors, neurotransmitters and enzymes key to healthy brain functioning and activity. 
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organs, making the brain particularly sensitive to oxidative stress and its effects (Dringen, 
1999). Finally, the non-regenerative nature of neurons ensures the brain is vulnerable to 
oxidative stress induced insults. Thus, maintenance of redox homeostasis in the brain is 
especially important.  
 
1.2. Antioxidant defence mechanisms 
 
Redox control has emerged as one of the most fundamental amongst the biological 
control mechanisms (Lincoln et al., 2003). The human body has natural defences to 
maintain redox homeostasis, partly through balancing the delicate equilibrium of ROS 
generation with antioxidative processes. Under normal conditions, several antioxidant 
systems work to scavenge and detoxify ROS and their precursors, repairing the normal 
redox state and mitigating oxidative stress. These antioxidant mechanisms work to bind 
catalytic metal ions required for ROS formation, as well as generate and upregulate more 













Figure 2: Schematic of antioxidant defences including SOD, CAT and GPx enzymes. Coloured in 
red are examples of cell generated ROS species and contributors to oxidative stress. Superoxide 
species are produced largely by mitochondria and NADPH oxidases. Resulting H2O2 can be 
reduced to H2O and oxygen by CAT enzymes, or to H2O by GPx enzymes, using glutathione (GSH) 
as a co-factor. Lastly, hydroxyl radicals are produced from H2O2 through the Fe2+/Cu2+ Fenton 
reaction.  
The first line of defence consists of a robust enzymatic antioxidant system which includes 
superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) (Nandi 
et al., 2019). NADPH oxidases and the mitochondrial respiratory chain are major sources 
of superoxide, which can then be converted into hydrogen peroxide by SOD enzymes. 








































(H2O2) in mitochondria. The resulting highly reactive H2O2 species can be reduced to 
stable H2O by CAT enzymes (Figure 2) (Birben et al., 2012), shown to be crucial in 
building cell tolerance to oxidative stress (Usui et al., 2009). The H2O2 species can also 
be converted to hydroxyl radicals through the Fe2+/Cu2+ Fenton reaction (Figure 2). The 
conversion of H2O2 to H2O can also be catalysed by glutathione peroxidases (GPx), 
enzymes which are also shown to act on other organic hydroperoxides.   
Reduced glutathione (GSH) acts as a co-factor for the breakdown of H2O2 by GPx 
enzymes and is converted to oxidised glutathione (GSSG) in the process. After being 
oxidised, glutathione reductase (GR) can reduce the GSSG back, using nicotinamide 
adenine dinucleotide phosphate (NADPH) as an electron donor (Figure 2). This 
glutathione redox cycle is shown to be most active during low levels of stress conditions, 
whilst CAT enzymes take over in protecting against severe oxidative stress (Lee et al., 
2020). Specifically, neurons are shown to have lower catalase levels than astrocytes 
(Baxter & Hardingham, 2016), as well as lower GSH levels (Dringen, 1999). As part of 
their glutathione metabolism pathway, astrocytes release glutamine, a GSH precursor 
(Hertz et al.,1999) which is taken up and used by neurons to feed into their own 
biosynthetic pathways required for neuronal GSH synthesis. Thus, neuronal GSH levels 
rely heavily on the speed and efficacy of this concurrent mechanism in astrocytes.  
 
1.3. Neuronal transcriptional regulation  
 
A further response to oxidative stress and constantly changing ROS levels is for neurons 
to change their gene expression. ROS, in modest doses, have long been established to 
function as intracellular signalling molecules despite their toxic nature. ROS species are 
considered essential as secondary messengers in a range of physiological functions 
including cell cycle progression, differentiation, immune responses and even cell death 
(Redza-Dutordoir & Averill-Bates, 2016). Redox regulated signal transduction has most 
often been found to be achieved through the reversible oxidation of protein cysteine 
residues. The cellular transcriptional response to ROS is mediated mainly by activation 
of kinase signalling cascades, such as the MAP protein kinase cascade, that in turn 
activate transcription factors such as AP-1 and ATF-1 (Zhang et al., 2016; Turpaev et 
al., 2002). In neurons, activation of c-Jun N-terminal kinase (JNK) signalling via ROS 
(Matsukawa et al., 2004) is shown to regulate neuronal plasticity and growth (Collins et 
al., 2006). The exact mechanism of ROS-mediated JNK activation is not known, however 
JNK is found to positively regulate neuronal antioxidant defense (Ugbode et al., 2020).    
The expression of several antioxidant genes, including those involved in glutathione 
biosynthesis and recycling, are induced by neuronal firing. Neuronal activity regulates an 
array of transcription factors (see section 1.5) that control plasticity-associated genes as 
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well as antioxidant genes. How neuronal transcription factors are regulated by increased 
synaptic firing is well studied, but their regulation under conditions of oxidative stress is 
poorly understood.  
Neuronal activity induced signalling pathways regulate both transcription factors and 
their co-activators and co-repressors, including the family of histone modifying enzymes. 
Such enzymes, which modify the epigenetic status of cells, provide attractive targets for 
therapy in disease (Jayathilaka et al., 2012). In this report, they are of special interest to 








Figure 3: Histone acetylation and deacetylation. Histone deacetylation via histone deacetylases 
(HDACs) causes tight chromatin compaction which inhibits access to DNA, causing gene 
repression. Histone acetylation via histone acetyltransferases (HATs) leads to relaxed chromatin, 
allowing greater access to DNA and target gene activation.  
The reversible modifications of histone acetylation and deacetylation have long been 
established as fundamental parts of gene regulation (Konsoula & Barile, 2012). The 
acetylation of the ε-amino group of lysine residues on the N-terminus of histones, via 
histone acetyltransferases (HATs), neutralises their positive charge and subsequently 
decreases their affinity for negatively charged DNA (Figure 3). This inhibits the 
generation of higher order chromatin structures, and so condensed chromatin becomes 
more relaxed, allowing for increased gene transcription. Conversely, the removal of the 
acetyl group through the action of histone deacetylase (HDAC) enzymes causes 
improved association with DNA, tighter chromatin compaction and significant decreases 
in gene transcription.  
 
1.4. Class IIa HDACs 
 
Histone deacetylases (HDACs) are zinc-dependent enzymes which function as 
epigenetic repressors, working to block transcription of many neuronal genes through 
this deacetylation process (Thomas & D'Mello, 2018). All HDACs are found to have a 
conserved set of active site residues used in a common mechanism for the hydrolysis of 
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through a charge relay system, requiring a Zn2+ ion. Generally, co-repressors are found 
to be required for HDAC activity (De Ruijter et al., 2003).  
The known mammalian HDACs are classified based on their homology to yeast HDACs 
(Blander & Guarente, 2004) and are divided into two groups based on structure, 
expression patterns and the specificity of their catalytic mechanism (Martin et al., 2007). 
Group I HDACs can be further divided into class I and class II enzymes based on 
sequence similarities, and additional domains allow even further subdivisions of class II 
HDACs into class IIa (HDAC4, -5, -7 and -9) and IIb (HDAC6 and -10).  
The IIa subclass of HDAC enzymes are characterised by the presence of a 450-600 
amino acid N-terminal extension of residues with distinct regulatory and functional 
properties, including cleavage and phosphorylation sites (Figure 4). The phosphorylation 
sites on conserved serine residues interact with the chaperone protein 14-3-3, which 
escort phospho-HDACs to the cytoplasm and sequester them there. Their N-terminal 
extensions also include a general/MEF2 transcription factor binding domain (MEF2) 
which allows interactions with transcription factors and enables their repressive activity. 
These N-terminal residues of HDAC4 and 5 play key roles in regulating their localisation, 
with the inclusion of a unique and strong nuclear localisation signal (NLS), and are 
necessary, but not sufficient, for their characteristic transcriptional repression activity. 
Conversely, the C-terminal end contains a highly conserved large deacetylase domain 
(DAC) and a hydrophobic nuclear export signal (NES) which is required for their 












Figure 4: Structural domains of class IIa HDACs 4 and 5. Summary of significant post translational 
modifications including phosphorylation (P), SUMOylation (S) and oxidation (O). Domains include 
a MEF2/transcription factor binding domain (MEF2), nuclear localisation signal (NLS), nuclear 
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This IIa subclass of HDACs are distinctly unique in a few ways. Firstly, whilst they can 
bind acetylated lysine, critical amino acid substitutions in their catalytic site are thought 
to cause catalytically inactive deacetylase domains (Haberland et al., 2009). Therefore, 
they require associations with the ubiquitously expressed and catalytically active HDAC3 
(a class I HDAC) in order to have any sort of deacetylase activity (Fischle et al., 2002).  
A H976Y histidine to tyrosine HDAC4 mutant was shown to have a 1000-fold increase in 
deacetylase activity compared to wildtype HDAC4 (Park and Kim, 2020). This tyrosine 
residue in the catalytic site is conserved in class I HDACs indicating a large difference 
between class I and class II HDAC deacetylase activities.  
Secondly, separate to other members of the family, class IIa HDACs are unique in their 
ability to shuttle between the nucleus and cytoplasm of neurons (Figure 5) in response 
to a number of diverse stimuli, including synaptic activity (Chawla et al., 2003). This 
nucleocytoplasmic shuttling mechanism is controlled through calcium dependent 
phosphorylation and cAMP dependent dephosphorylation of specific serine residues on 
the class IIa HDACs (Mielcarek et al., 2015). 
An increase in neuronal activity (such as with stimulus B) triggers Ca2+ influx into the cell 
through ligand and voltage gated Ca2+ channels leading to an activation of the 
Ca2+/calmodulin dependent protein kinases (CaMKII and CamKIV). These kinases 
phosphorylate two conserved serine residues on the class IIa HDACs, where these 
phosphorylation events mask the NLS and create a docking site for 14-3-3 chaperone 
proteins (Figure 5). Interactions with 14-3-3 proteins sequester class IIa HDACs in the 
cytoplasm through unmasking of the NES and preventing their interactions with importin-
α (Wang et al., 2001). This nuclear export means the class IIa HDACs can no longer 
work to repress their target gene transcription through binding transcription factors in 
association with HDAC3 (Liu et al., 2012).  
In contrast to the nuclear export triggered by Ca2+, cAMP signals (such as with stimulus 
A) induce a nuclear translocation of class IIa HDACs. The cAMP induced nuclear 
shuttling mechanism is thought to involve dephosphorylation of specific serine residues, 
triggering a dissociation of the 14-3-3 proteins (Figure 5). This dephosphorylation can be 
mediated by protein phosphatase A (PP2A) in the case of HDAC4 (Paroni et al., 2008), 
which associates with the N terminus of the HDACs, where PP2A activity is regulated by 






















Figure 5: Schematic of nucleocytoplasmic shuttling of class IIa HDACs. Intracellular signals such as 
stimulus A/B induce reversible pathways of class IIa HDAC shuttling between the nucleus and the 
cytoplasm via their phosphorylation status, enabling or disabling the repression of specific gene 
targets in the nucleus. (1) elevated cAMP levels activates PKA and PP2A (2) PP2A associates with 
the N terminus of class IIa HDACs and causes a dephosphorylation on serine residues, triggering 
14-3-3 to dissociate (3)  The class IIa HDACs shuttle into the nucleus (4) In association with HDAC3, 
the IIa HDACs can bind to transcription factors (TFs) and repress their gene targets (5) Influxes of 
Ca2+ into the cell allow CaMKII to phosphorylate the HDACs (6) The HDACs move to the cytoplasm 
and binding by 14-3-3 on their phosphorylation sites sequesters them in the cytoplasm.  
Bic/4AP (stimulus B) and Forskolin (stimulus A) are experimental ways to increase Ca2+ 
and cAMP respectively. Forskolin activates the enzyme adenylyl cyclase, increasing 
intracellular levels of cAMP. Bic/4AP treatment includes the GABA receptor antagonist 
bicuculline along with the K+ channel blocker 4-aminopyridine, which together increase 
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1.5. The role of transcription factors  
 
In recent years, HDACs have been shown to deacetylate both histone and non-histone 
proteins, including transcription factors (Bottomley et al., 2008). Many non-histone 
proteins have been shown to be deacetylated by HDACs, including cytoplasmic proteins 
(Parra, 2014). Specifically, the class IIb HDAC6 can deacetylate the cytoskeletal protein 
α-tubulin to regulate microtubule dependent cell motility (Hubbert et al., 2002). This 
demonstrates the ability of HDACs to not only regulate gene transcription but also 
important biological processes.  
Like other HDACs, the class IIa subfamily of HDACs do not themselves bind DNA but 
instead depend on interactions with sequence specific DNA binding proteins for their 
recruitment to promoter sites and genomic targeting (Jayathilaka et al., 2012). Once 
recruited by transcription factors, class IIa HDACs can influence the acetylation status of 
histones and the transcription factors themselves through association with 
HDAC3/SMRT/N-CoR co-repressor complexes (Figure 5). Two key neuronal 
transcription factor families targeted by class IIa HDACs are the MADS-box (MEF2) and 
the forkhead (FOXO) family of transcription factors.  
The MEF2 family of transcription factors are important regulators of neuronal 
development and differentiation and are heavily implicated in the adaptive stress 
responses of diverse tissues and organs (Potthoff & Olson, 2007). In the brain, they are 
actively involved in excitatory synapse number regulation (Flavell et al., 2006). Evidence 
of HDAC4-MEF2 interactions have been associated with HDAC4 nuclear import, MEF2 
inhibition (and resulting repression of MEF2 dependent genes) and ultimately neuronal 
cell death (Bolger & Yao, 2005).  
The function of transcription factors can be both positively and negatively affected by the 
binding of class IIa HDACs. Whilst MEF2-mediated gene transcription is repressed by 
the binding of these HDACs, the FOXO subfamily of transcription factors have been 
shown to be activated by class IIa HDACs during maintenance of glucose homeostasis 
(Mihaylova et al., 2011). FOXO transcription factors are implicated in the regulation of 
many cellular processes and are involved in critical cellular responses such as during 
oxidative stress (Accili & Arden, 2004). Separate to other transcription factor families, 
these FOXO factors are inactivated through lysine acetylation, reducing their DNA 
binding ability and altering their subcellular localisation. Increased cAMP levels cause a 
nuclear translocation of class IIa HDACs (as described in Figure 5) which, in association 
with HDAC3/N-CoR co-repressor complexes, interact with FOXO transcription factors in 
the nucleus. This interaction triggers a deacetylation and activation of the FOXO factors, 
allowing increased transcription of their gluconeogenic gene targets (Figure 6A). 
Conversely, phosphorylation of both the class IIa HDACs and FOXO factors through 
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serine/threonine kinase Akt dependent activation of AMP activated protein kinases 
(AMPK) causes their cytoplasmic retention and subsequent repression of their 
gluconeogenic gene targets (Figure 6B).  
For example, in the liver, class IIa HDACs deacetylate and activate FOXO1 in response 
to the fasting hormone glucagon to induce expression of gluconeogenic genes (Figure 
6A). Furthermore, during fasting in Drosophila melanogaster, AMPK kinases are 
inactivated causing dephosphorylation and a nuclear translocation of HDAC4 followed 
by FOXO deacetylation (Mihaylova et al., 2011; Wang et al.,  2011). FOXO transcription 
factors appear to have a role in protecting against oxidative stress through their function 
in transactivating a series of genes with critical roles in the cellular response to stress 
stimuli, including repair of damaged DNA (Gadd45) and ROS detoxification (MnSOD) 
(Brunet et al., 2004). Therefore, they present themselves as major players in 
neuroprotection during oxidative stress, and especially are of interest in relation to the 















Figure 6: Schematic of FOXO transcription factor regulation via class IIa HDACs. (A) Class IIa HDACs 
bind, deacetylate and active FOXO transcription factors in the nucleus allowing increased 
transcription of their gluconeogenic gene targets (B) Phosphorylation of FOXO factors and class 
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1.6. The neuroprotective nature of synaptic activity 
 
Another cog in the protective redox machinery in the brain appears to be neuronal activity 
itself. The idea that synaptic activity is neuroprotective has been of much interest in 
recent years, inspired by studies in which activity blockades cause death in disconnected 
target neurons (Mennerick & Zorumski, 2000). Whilst much of this research has focused 
on neuronal health during development, this work is also relevant in mature neurons. 
One key factor in neuronal health modulation, often dependent on synaptic activity and 
Ca2+ influxes, is changing and adapting vulnerability to oxidative stress (Bell & 
Hardingham, 2011), facilitated by anti-apoptotic genes being induced and pro-apoptotic 
genes being suppressed in response to synaptic activity. This is thought to be linked to 
the inactivation of transcription factors (such as FOXOs) controlling their expression. An 
example of these apoptotic genes includes the thioredoxin inhibitor Txnip, a FOXO target 
gene and a key antioxidant system component. The thioredoxin protective redox control 
system is a major player in the brain’s protection against oxidative stress. Txnip acts as 
an oxidative stress sensor by interacting with the reduced form of thioredoxin and 
inhibiting its activity. This can help sensitise cells (including neurons) to H2O2 induced 
death.  
There has also been much investigation into the induction of antioxidant genes during 
normal neuronal activity and therefore at physiological levels of ROS. This includes 
neuronal activity dependent changes in Ca2+ signalling and subsequent induction of 
antioxidant genes, including the glutathione (GSH) system. As discussed previously, 
neurons express comparatively low levels of GSH, but elevate GSH biosynthesis during 
bouts of increased synaptic activity. They can do this through transcriptional induction of 
genes encoding enzymes involved in the rate limiting step of the GSH biosynthesis 
process (Baxter et al., 2015). Synaptic activity also induces the expression of the 
antioxidant gene sulfiredoxin (SRNX1) as neurons recruit transcriptional induction of 
antioxidant proteins in order to adapt to synaptic inputs. Thus, numerous antioxidant 
defences are boosted when synaptic activity occurs, meeting the requirements for the 
subsequent increase in ROS production, through carefully balanced redox homeostasis 
in the brain (Qiu et al., 2020). Whilst this strategy is effective under normal conditions, 
the excessive level of ROS common in many neurodegenerative diseases appears to 

















Figure 7: Representation of the balance of pro-oxidants to antioxidants that allows redox 
homeostasis. Both cell generated and environmental factors contribute to excessive ROS and 
oxidative stress where antioxidants such as glutathione (GSH) and scavenging enzymes such as 
GPx, SOD and CAT all work to detoxify and counteract ROS in excess. 
Disruption of the careful ROS production and detoxification cycle, and the pro-oxidant to 
antioxidant balance (Figure 7) has been shown to contribute to the development of a 
number of human pathologies (Candas & Li, 2014). Strong links between the 
pathogenesis of many neurodegenerative diseases and the oxidative stress 
phenomenon has been found (Kim et al., 2015) where ROS increase susceptibility to 
neuronal damage. Evidence suggests that high levels of ROS are linked to neuronal 
death in various disorders (Popa-Wagner et al., 2013) and therefore delineating the 
mechanisms behind neuronal antioxidant defence mechanisms would be invaluable. 
Additionally, investigations of how these defences are regulated in both physiological 
and non-physiological contexts may contribute to the understanding of how they could 
be impaired in disease. Precise knowledge of the pathways involved is essential to find 
targets for treatment that would be both therapeutically beneficial and non-toxic to the 
brain. 
Whilst it is well established how synaptic activity regulates class IIa HDAC localisation, 
little is known about the effects of ROS on them. Despite this, these class IIa HDACs 
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1.8. HDAC4 and neurodegeneration 
 
HDAC4 specifically has been implicated in neuroprotection, where loss of HDAC4 has 
been shown to lead to neurodegeneration in the retina and cerebellum (Majdzadeh et 
al., 2008). Whilst cytoplasmic HDAC4 is shown to promote the survival of interneurons, 
translocation to the nucleus and the deacetylation of nuclear proteins (including 
transcription factors and histones) is thought to expedite death in cerebellar granule and 
purkinje neurons (Sando et al., 2012). This raises the possibility that the loss of synaptic 
excitation, or other signals which cause this nuclear translocation, may lead to 
neurodegeneration, partially through the depletion of cytoplasmic HDAC4.  
A recent study found that aspects of the neurodegenerative phenotype caused in PI3 
kinase deficient mice were rescued through either inhibition of HDAC4 activity or 
blockage of HDAC4 nuclear accumulation in cerebellar neurons (Li et al., 2012). 
However, alternate findings show that HDAC4 activity inhibition may exert detrimental 
effects on learning, memory and synaptic processes (Kim et al., 2012). Furthermore, 
nuclear HDAC4 is shown to repress genes known to be essential in synaptic function, 
including those encoding for constituents of central synapses. Therefore, any alterations 
in expression or activity of these genes may influence not only synaptic structure and 
functioning, but also information processing in the brain (Sando et al., 2012).   
Based on these findings, focusing on the alteration of the nucleocytoplasmic shuttling of 
HDAC4 instead of its complete inhibition may help in the consideration of future 
therapeutic approaches. Shifting the focus onto this dynamic shuttling pathway therefore 
















1.9. HDAC inhibitors  
 
Histone deacetylases have been shown to play dynamic and key roles in regulating a 
wide range of normal cellular activities. Studies have shown that alterations in HDAC 
expression or activity as well as imbalances in histone and non-histone acetylation are 
common in the development of many human cancers (Gallinari et al., 2007) and other 
syndromes (Reddy et al., 2018). As a result, multiple HDAC inhibitors (HDACi) have 
been developed and tested in clinical studies, and some approved as treatments. 
Inhibiting different HDACs in the brain has been reported to be neuroprotective and 
beneficial in many neurological conditions including Alzheimer’s (Lee et al., 2018) and 
Huntington’s disease (Bassi et al., 2017). 
Developed and currently used HDACi drugs fit into the active site pocket of Zn2+ 
dependent deacetylases. Such HDACis have been generally considered as pan 
inhibitors (Delcuve et al., 2012) but recent evidence has shown that most of these 
inhibitors do not specifically target class IIa HDACs (Bradner et al., 2010). Many of the 
available HDAC inhibitors are also associated with adverse effects. One of the major 
problems is the lack of specificity. Most inhibitors of the zinc dependent enzymes broadly 
target all class I and class II HDACs due to sequence similarities in their zinc containing 
catalytic sites. The level of specificity required to inhibit only the class IIa HDACs would 
be difficult to achieve as many of these deacetylases play important roles in cellular 
functions. Whilst general inhibition of HDAC expression or activity has been shown to be 
neuroprotective in some diseases, this approach in the brain could have detrimental 
effects without more thorough understanding of the neuronal specific function and 
































Figure 8: SRXN-1 overexpression rescues DEM-induced dendritic retraction (Figure from Ugbode 
et al, 2020). “Representative micrographs of mature neurons transfected with PSD95-GFP 
constructs alone (left panels) or in combination with Flag-tagged human SRXN-1 (right panels) ± 
100 μM DEM (48hr). Cells stained with anti-GFP (green), anti SRXN-1 (Flag antibody, red) and 
nuclear staining with DAPI (blue). Scale bar = 100 μm” (Ugbode et al., 2020).  
Whilst HDACi drugs may not be a plausible therapeutic outlook in the context of 
neurodegenerative conditions, recently published studies have shown how the 
manipulation of antioxidant gene expression could be a more promising approach. 
Recent studies demonstrate the possibilities of exploiting known antioxidant pathways in 
the brain to help prevent or even reverse neuronal ROS damages. Ugbode et al. (2020) 
found that overexpression of the antioxidant sulfiredoxin (SRXN-1) in rat neurons 
prevented dendritic loss (Figure 8) induced by long term glutathione depletion with diethyl 







1.11. Aims  
 
As class IIa HDACs have been linked with neuroprotection and neurodegeneration, this 
thesis aims to compare the regulation of class IIa HDACs under conditions of increased 
neuronal firing with conditions of oxidative stress generated by glutathione (GSH) 
depletion. Work described here investigates the subcellular localisation and 
phosphorylation status of class IIa HDACs in cultured primary rat cortical neurons during 
increased levels of synaptic activity and oxidative stress.  
Established experimental paradigms are used to increase neuronal firing in cortical 
neurons through bath applications of bicuculline, a GABA receptor antagonist, along with 
4-aminopyridine, a K+ channel blocker. Oxidative stress is induced by glutathione 















Figure 9: Schematic of diethyl maleate (DEM) action to deplete levels of neuronal glutathione 
(GSH), a key cellular antioxidant. Catalysed by glutathione-S-transferase, the formation of DEM-
GSH conjugates alters the GSH to GSSG ratio, decreasing GSH concentrations and inducing a state 
of oxidative stress. 
GSH homeostasis is found to be altered in many neurodegenerative diseases (Aoyama 
& Nakaki, 2015; Gu et al., 2015) and in the hippocampus of Alzheimer’s disease patients 
and mouse models of AD, GSH levels are notably decreased (Mandal et al., 2015; 
Resende et al., 2008). Glutathione depletion was achieved through treatments with 
diethyl maleate (DEM), an αβ unsaturated carbonyl (Plummer et al., 1981) with an 
electrophilic site, which is used as a substrate for glutathione-S-transferase (Deneke et 































Under normal conditions, GSH scavenge and detoxify ROS through donating electrons, 
ensuring they are not in excess and helping to maintain good neuronal health. 
Formations of DEM-GSH conjugates, catalysed by glutathione-S-transferase, causes an 
oxidising shift in the GSH to GSSG ratio, decreasing intracellular GSH concentrations 
(Figure 9). Depletions of GSH means less scavenging of ROS, causing excessive levels. 
Thus, oxidative stress conditions are induced, a state which can cause neuronal 
morphological damage or even cell death. 
Previous studies have demonstrated that depletion of cellular GSH leads to oxidative 
damage to rat brain proteins (Bizzozero et al., 2006). Applications of DEM in mature 
primary hippocampal rat neurons have recently been shown to cause concentration and 
time dependent decreases in cellular glutathione and increases in H2O2 secretion 
(Ugbode et al., 2020) causing oxidative stress, cytotoxicity and damage to neurons.  
Alternatively, oxidative stress was induced using Paraquat (PQ). This compound is part 
of a class of redox cycling compounds which produce ROS. PQ2+ is enzymatically 
reduced to its cationic radical (Reaction 1). This can reduce molecular oxygen to a 
superoxide radical, also regenerating PQ2+ (Reaction 2). The superoxide can then be 
converted to H2O2 either spontaneously (Reaction 3) or by superoxide dismutase 
(Reaction 4) (Figure 10).  
It has been shown that mitochondria are a major source of PQ2+ induced ROS generation 
(Castello et al., 2007), making it a somewhat mitochondrial specific induction of ROS 









Figure 10: Proposed production of H2O2 by PQ2+. A series of enzymatic reactions lead to the 
reduction of PQ2+ to the PQ+. radical (Reaction 1), which then reduces molecular O2 to a superoxide 
O2-. radical whilst regenerating PQ2+ (Reaction 2). The resulting superoxide species are converted 
to H2O2 spontaneously (Reaction 3) or through superoxide dismutase (SOD) (Reaction 4).  
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Some experiments were performed in transgenic Drosophila melanogaster expressing 
mammalian HDAC5. Drosophila have been used as a key model in neurodegenerative 
disease research for many years. This is partly due to high conservation between fly and 
human genes, their complex nervous systems and display of learning and memory 
behaviours (Chan & Bonini, 2000). The Drosophila class IIa histone deacetylase 
dHDAC4 and mammalian class IIa HDACs show similarities in key functional domains 
including regulatory phosphorylation sites. Compared to human HDAC4, Drosophila 
HDAC4 shows a 59% similarity across the whole protein and 84% similarity across the 
deacetylase domain containing C terminus (Fitzsimons et al., 2013). This suggests that 
the mechanisms regulating their subcellular localisation under conditions of oxidative 
stress are likely to be conserved.  
These factors make Drosophila an advantageous tool which can allow both the study of 
normal functions of proteins as well as the effects of targeted genetic mutations using 
expressions of human mutant forms of a protein. The GAL4-UAS system has been used 
extensively in Drosophila and applied more recently to model neurodegenerative 
















Figure 11: Schematic of the Drosophila GAL4/UAS system. A tissue specific enhancer drives 
GAL4 expression in a subset of cells which, when crossed with a UAS-target gene line, binds to 
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Developed in 1993, the GAL4-UAS system uses the yeast transcription activator protein 
GAL4, which specifically binds the upstream activating sequence (UAS) to activate gene 
transcription (Brand and Perrimon, 1993). Many GAL4 driver lines of Drosophila have 
been produced, under the control of a tissue specific enhancer and designed to express 
the GAL4 protein in a subset of tissues (Figure 11). The other necessary part of the 
system in Drosophila are reporter lines, which include the UAS region upstream of a 
gene of interest. This gene of interest is often tagged with an epitope or a fluorescent 
reporter, such as GFP, to allow visualisation of the expressed protein. The F1 progeny 
produced on crossing flies from the GAL4 driver line with a line containing the UAS-target 
gene express the gene of interest only in the cells in which GAL4 is present. Thus, the 
protein of interest is produced in a specific tissue such as neuronal cells.  
Throughout this thesis, four major treatments with different cellular effects are used in 
the study of the class IIa HDACs in neuronal antioxidant defences. For quick reference, 
the treatments used in this thesis and their actions are set out in Table 1 below:  
Table 1. Summary of treatments and their cellular effects.  
Treatment Description Effect 
Bic/4AP Includes bicuculline, a GABA receptor 
antagonist, and 4-aminopyridine, a K+ 
channel blocker. Known to drive 
cytoplasmic class IIa HDAC 
localisation 
Increases neuronal firing/ 
synaptic activity and 
intracellular Ca2+ 
DEM An αβ carbonyl which conjugates to 
GSH, catalysed by glutathione-S-
transferase 
Depletes GSH levels 
leading to higher ROS 
levels. Induces oxidative 
stress 
Paraquat Produces ROS through a series of 
enzymatic reactions, where 
mitochondria are a major source 
Increases (largely) 
mitochondrial specific 
ROS generation. Induces 
oxidative stress 
Forskolin Activates the enzyme adenylyl 
cyclase. Known to drive nuclear class 








2. Materials and Methods  
2.1 Drosophila genetic crosses 
 
Genetic crosses were designed to drive neuronal expression of GFP tagged human 
HDAC5 in transgenic Drosophila with the UAS promoter upstream of either: 
1. EGFP 
2. Wild type, GFP tagged human HDAC5 (HDAC5-GFP)  
3. GFP tagged, double phosphorylation site mutant* HDAC5 (HDAC5-DM) 
*This mutation of serine 259 and 498 on human HDAC5 to alanine residues (as 
described in Soriano et al., 2013) renders HDAC5 constitutively nuclear. The UAS-EGFP 
flies were provided by Dr. Chris Elliott (University of York). The UAS-HDAC5 GFP 
transgenic flies were generated by microinjection of Drosophila embryos (Chawla and 
Sweeney, unpublished).  
Crosses were designed using the UAS-GAL4 system, where nSyb115 is a neuronal driver. 
The crosses were set up as follows: 
 
nSyb115 GAL4 x UAS-EGFP 
nSyb115 GAL4 x UAS-HDAC5-GFP 
nSyb115 GAL4 x UAS-HDAC5-DM 
 
Virgin nSyb115 females were identified, collected and stored separately until the set-up of 
a new cross. Males were selected from stocks of each genotype, where straight winged 
males only were selected for HDAC5-GFP, and orange eyed males only for HDAC5-DM 
flies as these phenotypes served as markers for the presence of the UAS-HDAC5 
transgene. Crosses were set up by placing 8-10 males and 6 virgin females in a vial. 
After 7 days the parents were removed, and larvae allowed to develop. F1 progeny flies 
were collected after 10 to 12 days post set up of the cross. F1 progeny flies were collected 
(both females and males) and frozen at -70 °C for future use.  
Alternatively, the same crosses were set up, parents removed, and the collected F1 
progeny were then put on either ethanol (EtOH) control or 5 µM DEM (Sigma) food for 3 
days or 1 week. 
5 µM ethanol (EtOH) and DEM fly foods were prepared with defined media, 10% sucrose, 
5% yeast and sawdust (see appendix for details of food preparation).  
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2.2 Protein Extraction 
 
The collected flies produced from the genetic crosses (section 2.1) were removed from 
the -70°C freezer, the tubes vortexed, and the fly heads separated from the bodies using 
a microscope and tweezers. Around 10 heads per genotype were extracted and placed 
into fresh tubes. To these tubes, 50 µl 1 x RIPA was added, and they were homogenised 
with 20+ rotations using a pestle. 1 x RIPA was made using 200 µl 5 x RIPA stock (50 
mM Tris, 150 mM NaCl, 1% (v/v) Triton-X-100, 0.5% (w/v) sodium deoxycholate, 0.1% 
(w/v) SDS, 1 mM EDTA, 1 mM NaVO43) and 800 µl de-ionised water (dH2O), then 0.1% 
(v/v) β-mercaptoethanol, 0.5% (v/v) PMSF and a protease inhibitor cocktail was added 
to the 1 x RIPA stock. The tubes were thawed on ice and vortexed before being 
centrifuged for 5 minutes, at 13 k rpm speed and 4°C. The supernatant was removed 
and pipetted into a fresh tube. 10 µl 4 x LDS sample buffer (NuPAGE, Thermo Fisher 
Scientific) was added to 30 µl supernatant and the tubes stored at -20°C before use on 
a western blot.  
35 mm dishes of cultured cortical neurons, treated as stated, were washed with 1 x PBS 
and lysed in 450 µl 1 x RIPA buffer using cell scrapers. The cells were scraped into tubes 
and incubated on ice for 10 minutes. The lysates were then centrifuged at 16.1 rcf and 
4°C for 10 minutes. Around 100 µl of supernatant was collected and 33 µl 4 x LDS sample 
buffer (NuPAGE, Thermo Fisher Scientific) + 20 mM DTT was added. The tubes were 














2.3 Antibodies used  
 
The following antibodies were used for western blotting and immunohistochemistry with 
dilutions as stated in Table 2 (primary antibodies) and Table 3 (secondary antibodies).  
Table 2. Primary antibodies used for western blotting and immunohistochemistry experiments. 
Name Supplier Dilutions 




1:1000 (western blotting), 
1:200 (immunohistochemistry) 
p-HDAC4 (S246)/ HDAC5(S259)/ 




1:1000 (western blotting), 
1:200 (immunohistochemistry) 
p-HDAC4 (S632)/ HDAC5(S498)/ 
HDAC7(S486) (3424S) Rabbit 
monoclonal antibody 
Cell Signalling 
Technology 1:1000 (western blotting) 
HDAC4 (D15C3) Rabbit 
monoclonal antibody 
Cell Signalling 
Technology 1:100 (immunohistochemistry) 





1:1000 (western blotting) 
GFP (132 005) Guinea pig 
polyclonal antibody 
Synaptic 
systems 1:1000 (western blotting) 
NeuN (ABN90) Guinea Pig 
polyclonal antibody Millipore 1:500 (immunohistochemistry) 
 
Table 3. Secondary antibodies used for western blotting and immunohistochemistry 
experiments. 
Name Supplier Dilutions 
Goat anti Rabbit Alexa 488 
(A11008) Invitrogen 1:500 (immunohistochemistry) 
Goat anti Guinea Pig Alexa 546 
(A11074) Invitrogen 1:500 (immunohistochemistry) 
HRP conjugated anti-rabbit (111-
035-114) Jackson 1:10,000 (western blotting) 
HRP conjugated anti-guinea pig 
(106-035-003) Jackson 1:2000 (western blotting) 
HRP conjugated anti-mouse 







2.4 Western blotting  
 
Western blotting techniques were used to detect levels of selected proteins in samples. 
See appendices for additional details of gel components and buffers.  
Samples were run on 10 well, 10% SDS PAGE gels in 1 x Laemmli running buffer (0.025 
M Tris, 0.192 M glycine, 0.1% SDS, pH 8.3) with a 5 µl preceding molecular weight 
marker (Bio-Rad Precision Plus Dual Colour Standards). This was run at 120V until the 
dye front reached the resolving gel, then 180V for 1 hour or until the dye ran off the edge 
of the gel.  
The gel was then transferred overnight at 20V onto 0.45 µm PVDF membrane 
(Immobilon, Merck Millipore), previously wet using methanol. The membrane was 
checked for complete transfer using Ponceau S stain, then de-stained with 1 x PBS 
washes. The membrane was then blocked in either 5% milk powder in PBS or 3% BSA 
in PBS for 1 hour at room temperature with constant shaking.  
After blocking, the membrane was incubated in the primary antibody, previously diluted 
to the recommended dilution in 5% BSA in 1 x TBST (20 mM Tris, 150 mM NaCl, 0.1% 
(w/v) Tween-20 detergent), for at least 3 hours at room temperature or overnight at 4 °C 
with constant shaking.  
After incubation, the membrane was washed 3 x 10 mins in TBST with gentle agitation. 
The first wash used ~100 ml TBST and the last two washes used PBS. 
After the washes, the membrane was incubated with the HRP-conjugated appropriate 
secondary antibody. The secondary antibody was diluted at the recommended 
concentration in 5% milk powder in PBS + 0.5% Tween-20. The membrane was 
incubated with constant shaking at room temperature for 1 hour at room temperature.  
After this incubation, the membrane was again washed 3 x 10 mins as previously 
described. After the last wash, the membrane was incubated in 600 µl of luminol then 
600 µl of peroxide ECL reagents (Thermo Fischer Scientific) and carefully agitated for 1 
minute in this mixture. In the dark room, a piece of film was exposed to the blot which 
had been dried, sealed in cling film and taped into a film cassette. Once exposed, the 
film was placed into a tray with developer and agitated for 20-30 seconds, then washed 
and placed in a tray with fixer and again agitated. The film was finally removed, washed, 
and left to dry outside the dark room. The film was marked with the molecular weight 
markers and labelled.  
Adjustments were made to the protocol, e.g. dilution of primary and secondary 
antibodies, length of antibody incubation and length of time film exposed to blot to 




Cultured rat neurons, 14 days in vitro, were treated for 2 hours and fixed onto coverslips 
for later staining. The cells were rinsed with 1.5 ml PBS and fixed for 20 minutes with 1 
ml fixative (3% paraformaldehyde, 4% sucrose in PBS) at room temperature. The cells 
were then washed three times in PBS, at which point the coverslips were stored in PBS 
in the cold room at 4 °C.  
From the cold room, the coverslips were placed in a 6 well plate with 1 x PBS. The 
coverslips were permeabilised with 0.5% NP-40 in PBS for exactly 5 minutes, then 
washed in PBS. Droplets of 48-50 µl of primary antibody, diluted to the recommended 
dilution, were pipetted onto parafilm in a humidified chamber and coverslips placed cell 
side down onto the droplets. The box was sealed, and coverslips left to incubate at room 
temperature for at least 1 hour, or overnight at 4 °C.  
After incubation, the coverslips were placed back into the 6-well plate with fresh PBS 
and washed for 3 x 5 minutes. The coverslips were then incubated in 500 µl of diluted 
secondary antibody for 1 hour at room temperature in the 6-well plate. After incubation, 
the coverslips were washed 2 x 5 minutes in PBS, then incubated in 500 µl Hoechst stain 
to stain nuclei for 5 minutes before washing twice again in PBS for 5 minutes. The 
coverslips were then mounted onto microscope slides with one drop of fluoromount 
mounting medium (Sigma) and sealed with nail varnish. The microscope slides were 
stored at 4 °C until imaging. 
 
2.6 Fly brain dissections  
 
Live flies taken from crosses in section 2.1 were anaesthetised and collected. The heads 
were separated from bodies, and the fly brains were dissected using tweezers under a 
microscope. The dissected fly brains were fixed with 4% PFA for 15 minutes before being 
transferred to PBS. After washing in PBS, the brains were mounted onto microscope 
slides with fluoromount and sealed with nail varnish before being imaged immediately. 
All dissections were performed by Chris Elliott.  
 
2.7 Fluorescence microscopy 
 
Images were taken on an inverted Zeiss microscope (880) with 20x objective using Zeiss 
filter sets for DAPI, Alexa 488 and 546. For each treatment (coverslip), 3 areas that 
included roughly 10 cells each were imaged for analysis. Consistent settings were used 
to image the areas at a resolution of 1072x1072 pixels. Images were imported into 
ImageJ for analysis (see section 3.1).  
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2.8 RNA isolation (neurons) 
 
After treatment of cultured rat neurons, growth media was removed and 1 ml TRIzol 
reagent (Thermo Fisher Scientific) was added to the cells. Cell scrapers were used to 
lyse and scrape the cells into tubes, and the homogenised samples were left to sit for 5 
minutes at room temperature. 200 µl of chloroform was added and the tubes were 
shaken vigorously by hand for 15 seconds. The samples were again incubated for 2-3 
minutes at room temperature, before being centrifuged at 4 °C for 30 minutes. The 
aqueous phase was removed by angling the tubes at a 45 ° angle and pipetting out the 
upper ~50% colourless section into a new tube. 500 µl isopropanol was added to the 
~500 µl extract, adjusting based on the amount extracted in a 1:1 ratio. The tubes were 
then vortexed and stored at -20 °C at least overnight. 
The samples were removed from the freezer and centrifuged for 1 hour at 4 °C. The 
supernatant was removed from the tubes without disrupting the pellet and discarded. 
500 µl of 75% ethanol containing DEPC water was carefully added to the tubes with 
pellets, and they were centrifuged for 15 minutes at 4 °C. The ethanol wash was carefully 
removed, leaving the pellets intact. The pellets were left to dry in the tubes with the lids 
open for 10 minutes at room temperature. 50 µl DEPC water was added to the pellets, 
which were then vortexed and frozen at -70 °C.  
 
2.9 RNA isolation (flies) 
 
50 µl TRIzol was added to roughly 20 frozen fly bodies or 50 frozen fly heads which were 
homogenised immediately with disposable plastic pestles. 750 µl TRIzol was then added 
to these homogenised samples which were incubated at room temperature for 5 minutes. 
The samples were centrifuged for 15 minutes at 12 k rcf at 4 °C to pellet the insoluble 
debris. The supernatant was carefully transferred to a new tube, leaving 50 µl of liquid at 
the bottom and not disrupting the fatty pellet. 160 µl of chloroform was added to the 
supernatant tubes and shaken vigorously by hand for 15 seconds, leaving them to 
incubate for 2-3 minutes at room temperature. The samples were centrifuged at 12 k rcf 
for 15 minutes at 4 °C.  
The upper aqueous phase was then pipetted out and transferred to a new tube. 400 µl 
of isopropanol was added, and the tubes were vortexed briefly. The samples were then 
incubated in the fridge (4 °C) for 30 minutes before being centrifuged at 12 k rcf for 30 
minutes at 4 °C. The supernatant was removed, and the pellet washed with 1 ml 75% 
ethanol containing DEPC water. The tubes were then centrifuged again at 12 k rcf for 5 
minutes at 4 °C and the supernatant removed. The tubes were again centrifuged briefly 
before any remaining supernatant was removed so that no liquid remains. The pellets 
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were air dried for 10 minutes at room temperature before being resuspended in 50 µl 
RNAse free DEPC water, vortexed and frozen at -70 °C.  
 
2.10 Reverse transcription  
 
The RNA samples extracted from either neuronal cells (section 2.8) or flies (section 2.9) 
were measured for optical density (OD) to estimate the concentration of the extracted 
samples. The OD (wavelength 260 nm) is measured after one -70 °C freeze cycle (at 
least overnight). 2 µl of the RNA extracts was pipetted into 100 µl DEPC water and the 
diluted RNA samples were run on the spectrometer (with DEPC water alone as a 
reference and the OD recorded).  
Once the ODs of the RNA samples were measured, the samples were DNAsed. This 
was done through mixing the reagents set out in Table 4.  
Table 4. Reagents and amounts for DNase treatments of RNA extracts. 
Amount Reagent 
10 µg (estimated using ODs) RNA 
5 µl 10 x DNAse I buffer 
2 µl RNAse free DNAse (Sigma) 
1 µl  Ribolock RNAse inhibitor (Thermo Fisher Scientific) 
Up to 50 µl DEPC water 
 
This mixture was incubated for 1 hour at 37 °C. After this, 6 µl of 25 mM EDTA was then 
added and the mix was incubated for 10 minutes at 65 °C.  
Reverse transcription was performed to synthesise cDNA from the RNA extracts. This is 
done through mixing the reagents set out in Table 5.  
Table 5. Reagents and amounts used for reverse transcription. 
Amount  Reagent 
10 pg – 5 µg  DNAsed total RNA 
1 µl 50 µM oligo(dT)20 
1 µl 10 mM dNTP mix 
Up to 14 µl  DEPC water 
 
This was run on a PCR machine, which heated the mixture to 65 °C for 5 minutes. The 
samples were then incubated on ice for 5 minutes and the following was added as set 
out in Table 6.  
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Table 6. Reagents and amounts used for the oligo dT program. 
Amount Reagent 
4 µl 5 x first strand buffer 
1 µl 0.1 M DTT 
0.5 µl RNAse inhibitor 
0.5 µl SuperScript IV RT (Thermo Fisher Scientific) 
 
The tubes were then run on a PCR machine as follows: 
25 °C for 5 minutes 
50 °C for 10 minutes 
80 °C for 10 minutes  
Stable at 4 °C after the reaction had finished.  
The resulting cDNA samples were frozen at -20 °C.  
 
2.11 qPCR  
 
Primers for desired genes were designed using primer BLAST and selected for based 
on the categories of 50-60% GC content, 50-65 °C Tm and low self-complimentary.  Both 
exon-exon junction restricted and no preference searches were made. The desalted 
primers were made up with de-ionised water according to the recommendations by the 
manufacturer for each specific primer.  
Each primer was tested, and selected if multiple of one gene ordered, by running on an 
1.2% agarose gel in 1 x TAE buffer to look for strong bands, tested with relevant cDNA 
to the experiment. The agarose gel was made with 0.6 g agarose in 500 ml 1 x TAE 
buffer, with 2 µl cybersafe dye. The bands were visualised using a UV light box.  
For this, the following was mixed in a tube and centrifuged briefly as set out in Table 7.  
Table 7. Reagents and amounts for RT-PCR reactions with primers to be tested. 
Amount Reagent 
5 µl cDNA 
12.5 µl 2 x PCR mix 
2 µl 5 µM forward and reverse primer mix 





The samples were then run on a PCR machine as follows:  
94 °C for 2 minutes for denaturing DNA and activating the polymerase 
25-35 cycles of 94 °C for 30 seconds 
60 °C for 30 seconds 
72 °C for 1 minute per Kb, 
72 °C for 10 minutes for final extension 
4 °C after the reaction has finished.  
Samples were stored at - 20 °C until use.  
 
For the qPCRs, 96 well plates were pipetted as indicated. 
Each sample (well) contained the following reagents as set out in Table 8.  
Table 8: Reagents and amounts in each well of the qPCR plate. 
Amount Reagent 
10 µl Fast SYBR Green master mix (ThermoFisher) 
2 µl Forward and reverse primer mix 
3 µl  dH2O 
+  
5 µl  cDNA 
 
The qPCR reactions were run in duplicate on a StepOneTM Real-Time PCR System 
(Applied Biosystems). Relative expressions were determined by the 2-∆∆CT method. A 
control well was selected for normalisation (Gapdh for neurons, Rpl1 for flies).  
Duplicate cDNA samples of each treatment including control (untreated) were pipetted 
when running the qPCRs with different primers. Normalisation to the house keeping gene 
Gapdh/Rpl1 was conducted for individual wells within the duplicates. Data from individual 
wells was excluded if a high standard error (SD) was displayed between duplicate wells 
with the same primer and treatment. Primers were previously checked for specificity of 
a single product using agarose gels (see above, page 35) to confirm that the primers 
tested generated a single band in a PCR reaction. Melt curves were additionally used to 
confirm that each primer generated a single peak during running of the qPCR.  
The qPCR data was analysed through taking the relative expression (RQ) values for 
each well (treatment) and dividing the values against the control well of that gene for 
normalisation. This normalised relative expression value was averaged across the 
stated number of experiments, the mean plotted, and SEM displayed as error bars. 
Statistical analysis was performed for the mean RQs for each treatment against the 
control RQ (value = 1) using one-way ANOVAs and post-hoc tests as stated.  
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The primers used were as follows (Table 9). 














































2.12 Culture of neurons  
 
Cortical neurons were cultured as described in Ugbode et al., 2020. Cultures were 
treated with cytosine arabinoside (AraC) at 1 day in vitro to inhibit any contaminating 
astrocytes in the neuronal cultures. 
All treatments were performed in the absence of serum and growth factors in a defined 
medium called Transfection medium (TM), which is made up of 10% Minimal essential 
medium (Invitrogen) and 90% Salt-Glucose-Glycine (SGG) medium (SGG composition: 
114 mM NaCl, 0.219% NaHCO3, 5.929 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM 
HEPES, 1 mM Glycine, 30 mM Glucose, 0.5 mM sodium pyruvate, 0.1% Phenol Red). 
The TM was supplemented with insulin/transferrin/selenium (4140045, Thermo 
Scientific), penicillin (50 U/ml) and streptomycin (50 µg/ml). Neurons were in TM for 24 
hours prior to treatments with DEM, bicuculline/4-aminopyridine, paraquat, TTX or 
forskolin at concentrations and durations as stated. 






















3. Localisation and post-translational modifications of class IIa HDACs 
It is well established that increases in synaptic activity in neurons can cause a 
cytoplasmic translocation of class IIa HDACs through Ca2+ signalling and subsequent 
activation of kinases (Chawla et al., 2003). In contrast, an increase in cellular cAMP in 
neurons by bath application of forskolin is known to induce a nuclear translocation 
(Belfield et al., 2006). Nevertheless, little is known about the localisation of these class 
IIa HDACs in the brain under conditions of oxidative stress. This chapter aims to 
investigate the effect of imposed oxidative stress on the subcellular localisation of 
HDAC4 and HDAC5 in primary cultured rat cortical neurons.  
This chapter includes the findings that overall oxidative stress conditions, induced by 
DEM treatments, drive a nuclear translocation of both endogenous HDAC4 and HDAC5 
in rat neuronal cells. Investigations into HDAC5 phosphorylation levels revealed some 
evidence of HDAC5 dephosphorylation after treatments with DEM, supporting the 
findings of its nuclear accumulation in the same conditions. Oxidative stress induced by 
paraquat, on the other hand, causes a primarily cytoplasmic and often punctate 
localisation of HDAC4. Inducing synaptic activity through treatments with Bic/4AP drives 
a largely cytoplasmic distribution of HDAC4 and HDAC5, as expected. Interestingly, 
combining DEM and Bic/4AP treatments led to even stronger cytoplasmic localisations 
of these HDACs. The nuclear shuttling of HDAC4 and 5 under oxidative stress is a novel 
finding and worthy of further investigations, as the mechanism underlying their ROS-
induced nuclear translocation has relevance to neurodegenerative disease. This is 
especially relevant given the reported nuclear localisation of HDAC4 in Alzheimer’s 
















3.1. Oxidative stress causes a nuclear translocation of class IIa HDACs 
To investigate whether oxidative stress alters the localisation of HDAC4/5 in neurons, 
immunostaining for endogenous HDAC4 and HDAC5 was performed in rat cortical 
neurons at 14 days in vitro. Localisation of HDAC4 and 5 was compared in neurons 
treated with bicuculline and 4-AP to increase synaptic activity; forskolin to increase cAMP 
levels; DEM and paraquat to increase ROS. Figure 12 shows representative confocal 
images of neurons fixed 2 hours after 100 µM DEM treatment and probed using an 
antibody to HDAC5 (Fig 12A) or HDAC4 (Fig 12B). Neurons were distinguished from 
astroglia by co-staining with an antibody to the neuronal marker protein NeuN.  
In the untreated or control condition (- DEM), HDAC5 is localised in both the cytoplasm 
and the nucleus of neurons. In DEM treated neurons, HDAC5 immunoreactivity is 
strongly nuclear, suggesting that DEM induces a nuclear translocation of HDAC5 (Figure 
12A). A similar localisation change was also observed for HDAC4 under the same DEM 
treatment (Figure 12B), but with a less marked change.  
In contrast to DEM, treatments with 100 µM paraquat caused opposite reactions in 
HDAC4 and 5. Whilst HDAC5 translocated to the nucleus as it did with DEM treatment 
(Figure 13A), HDAC4 was observed as being more cytoplasmic after strong doses of 
















































Figure 12: HDAC4 and 5 localise to the nucleus in neurons following DEM treatment. 
Representative confocal images displaying examples of cells showing localisation of (A) HDAC5 
and (B) HDAC4 in immunostained cortical rat neurons. Neurons were left untreated (- DEM) or 
treated for 2h with 100 µM DEM (+ DEM). Green fluorescence signal represents HDAC4/5 
immunoreactivity. Neurons were co-stained with NeuN, a neuronal marker, showing in red the 
whole of the neuronal cell. Nuclei were stained with Hoechst stain, showing in blue the location 
of the nucleus compared to the rest of the cell. The overlay displays the localisation of the green 
fluorescence HDAC4/5 immunoreactive signal in the context of the neuronal cells. Images taken 
















































Figure 13: HDAC4 and 5 translocate in different directions in neurons following paraquat 
treatment. Representative confocal images displaying examples of cells showing localisation of 
(A) HDAC5 and (B) HDAC4 in immunostained cortical rat neurons. Neurons were left untreated (-
Paraquat) or treated for 2h with 100 µM paraquat (+ Paraquat). Green fluorescence signal 
represents HDAC4/5 immunoreactivity. Neurons were co-stained with NeuN, a neuronal marker, 
showing in red the whole of the neuronal cell. Nuclei were stained with Hoechst stain, showing 
in blue the location of the nucleus compared to the rest of the cell. The overlay displays the 
localisation of the green fluorescence HDAC4/5 immunoreactive signal in the context of the 
neuronal cells. Images taken at x20 objective. Scale bar = 35 µm. 
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A quantitative analysis of these confocal images was performed: for each treatment, the 
percentage of cells showing HDAC4 and 5 immunoreactivity in the cytoplasm, nucleus, 
or both were determined. Images were analysed with ImageJ. Within ImageJ, a line was 
selected over the individual cell and the immunofluorescence signal was plotted across 
the distance of the cell (Figure 14). Comparing these plots with the images of the selected 
cells, it was possible to classify the fluorescent signal as either cytoplasmic, nuclear or 
both. A peak in the middle of the cell (Figure 14C) was classified as nuclear, a trough in 
the middle (Figure 14A) classified as cytoplasmic and a constant signal across the whole 
cell (Figure 14B) was classified as both. Bic/4AP treatment was used to increase 
synaptic activity and forskolin treatment to increase cAMP levels with these conditions 



















































Figure 14: Representative examples of neuronal cells classed as cytoplasmic, nuclear or both 
HDAC4/5 immunoreactivity. Representation of how individual neuronal immunostained cells 
were analysed using ImageJ and classified as either (A) cytoplasmic, (B) both or (C) nuclear. In 
ImageJ, a line was selected across each cell (left panels) to measure the fluorescent green signal 
across the distance of the cell. The blue Hoechst stain show the location of the nuclei of the cells. 
Cells were classified based on representative images and the rough shape of the plots (right 
panels) as either having a trough in the middle of the cell (where the nucleus is) and being 
cytoplasmic, a peak in the middle and nuclear, or roughly the same signal across the distance of 
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Figure 15: Synaptic activity and oxidative stress generate distinct subcellular distributions of 
HDAC5 and HDAC4 in neurons. Neurons were treated for 2 hours with the indicated treatments 
or left untreated (control) and stained for HDAC4 or HDAC5. Neurons in each treatment group 
were classified as showing cytoplasmic (light grey), both (dark grey) or nuclear (black) localisation 
and the percentage of cells in each category was plotted for HDAC5 (A) and HDAC4 (B). The mean 
percentages from 3 independent experiments are shown. Error bars indicate ± SEM. Localisation 
was assessed in roughly 150 cells per independent culture. (*P<0.05 One way ANOVA followed 










































































































cultures). The asterisks indicate statistically significant differences between control and treated 
neurons in the indicated localisation category. 
As observed in the confocal images of the cells, quantitative analysis shows that HDAC5 
in neurons is both cytoplasmic and nuclear in control conditions, with a very low 
proportion of cells (6.99 ± 3.86%) showing exclusively cytoplasmic localisation and 26.34 
± 4.77% of cells showing exclusively nuclear HDAC5 immunoreactivity (Figure 15A). 
HDAC4, on the other hand, is cytoplasmic in much higher proportion of cells (44.61 ± 
1.36%) under control conditions with very few neurons display exclusively nuclear 
immunoreactivity (3.22 ± 0.81%) (Figure 15B). 
Increased synaptic activity induced by Bic/4AP treatments show a cytoplasmic shuttling 
of both HDAC4 and 5, as expected in accordance with previous studies (Chawla et al., 
2003). Forskolin treatments show a movement of both HDAC4 and HDAC5 towards the 
nucleus, also as expected, with HDAC5 being strongly nuclear in this condition. Whilst 
HDAC4 has movement towards a nuclear localisation, a substantial proportion (33.33%) 
of the classified cells are still categorised as both cytoplasmic and nuclear with forskolin 
treatment (Figure 15B).  
The data in Figure 15 confirms the nuclear translocation of both HDAC4 and 5 in 
response to DEM-induced oxidative stress conditions. Both HDAC4 and 5 show a 
nuclear shuttling in response to DEM in a dose-dependent manner, with higher 
concentrations of DEM (100 µM) causing a more marked change (a nuclear distribution 
increase of 3.22% to 72.54% for HDAC4 and 26.34% to 84.46% for HDAC5) compared 
with lower concentrations (10 µM) (an increase of 3.22% to 54.75% for HDAC4 and 
26.34% to 72.55% for HDAC5). For HDAC5, 10 µM DEM treatments show very similar 
localisation to forskolin treatment, with over 70% of cells analysed displaying nuclear 
immunoreactivity. HDAC4 also shuttles to the nucleus following DEM treatment, but 
based on the data in both Figure 12 and Figure 15, the DEM-induced HDAC4 nuclear 
translocation (72.54 ± 1.06% nuclear following 100 µM DEM treatment) is less 
pronounced than for HDAC5 (84.46 ± 11.97% nuclear following 100 µM DEM).   
Oxidative stress conditions induced by paraquat treatments had similar effects on 
HDAC5 localisation as DEM, but markedly different effects on HDAC4 localisation. 
Similar to DEM, paraquat treated neurons showed a dose-dependent nuclear 
translocation of HDAC5 in Figure 15A. HDAC4 on the other hand, displayed a 
predominantly cytoplasmic localisation in response to both low (10 µM) and high 
concentrations (100 µM) of paraquat treatments (Figure 15B) with 57.94 ± 5.94% of cells 
showing cytoplasmic HDAC4 in 100 µM paraquat compared to 44.61 ± 1.36% of cells 
showing cytoplasmic HDAC4 in control conditions.  
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When looking at the proportion of HDAC5 stained cells stained showing a cytoplasmic 
localisation, the DEM, paraquat and forskolin treatments show no difference compared 
to the control treatment, whilst bath application of bicuculline and 4-aminopyridine 
causes an increase from 6.99% to 55.97% of cells displaying cytoplasmic HDAC5 
distributions. When comparing the percentage of cells showing a nuclear HDAC5 
localisation, Bic/4AP treatments cause a decrease in nuclear HDAC5 from 26.34% to 
7.97% whilst DEM, paraquat and forskolin cause highly significant increases in cells with 
a nuclear HDAC5 distribution (Figure 15A). The 10 µM DEM, paraquat and forskolin 
treatments show very similar nuclear localisations in cells stained for HDAC5, indicating 
they are driving a similar HDAC5 translocation mechanism at these concentrations.   
On the other hand, when comparing the proportion of nuclear HDAC4, Bic/4AP and 100 
µM paraquat treatments show little difference in comparison to control, whilst 10 µM DEM 
and forskolin cause increases from 3.22% to 54.75% and 66.67% respectively. For 
cytoplasmic HDAC4 distributions, 100 µM DEM shows a decrease from 44.61% in the  
control condition to 7.14%. Meanwhile, 100 µM paraquat induces an increase of 
cytoplasmic HDAC4 to 57.94%, indicating an opposing localisation pattern to that found 
after high concentration DEM treatment.  
Given that synaptic activity and DEM had opposing effects on HDAC4/5 localisation, the 
effect of combined treatment with both Bic/4AP and 10 µM DEM was also investigated. 
The combination of these treatments was used to help elucidate the mechanism by which 
DEM drives a HDAC4/5 nuclear translocation. It was hypothesised that DEM either 
inhibits the normal processes involving class IIa HDAC nuclear export or activates 
independent mechanism for their nuclear import.  
Under these conditions, both HDAC4 and 5 showed predominantly cytoplasmic 
localisations (Figure 15) and interestingly, this cytoplasmic translocation with the 
combined treatment was more marked than with just Bic/4AP treatment alone.  
 
3.2. High concentrations of paraquat causes HDAC4/5 accumulation in distinct 
immunoreactive puncta 
 
During imaging of both HDAC4 and HDAC5 immunostained cells, occurrences of 
immunoreactive puncta were observed in the 100 µM paraquat treated neurons (Figure 
16). The appearance of puncta was observed in the perinuclear region of the cytoplasm 
for HDAC4 (Figure 16A) and HDAC5. However, puncta were also observed in the 
nucleus for HDAC5 as shown in Figure 16B. This discrete pattern of immunoreactivity 
was not observed in NeuN stained images and therefore is unlikely that paraquat is 

































Figure 16: HDAC4 and 5 immunoreactive puncta are observed in neurons following high 
concentrations of paraquat treatment. (i) Representative images of examples of HDAC4 and 
HDAC5 immunoreactive puncta in neurons following 100 µM paraquat treatments. Examples of 
100 µM paraquat treated neurons are shown with (A-B) HDAC4 and (C) HDAC5 immunoreactivity. 
(ii) A closer look at examples of punctuative fluorescent signal images from (A) and (C). Green 
fluorescence signal represents HDAC4/5 immunoreactivity. Neurons co-stained with NeuN, a 



























3.3. Oxidative stress causes a dephosphorylation of HDAC5 
The data thus far show a marked change in HDAC4/5 localisation from mainly 
cytoplasmic in control conditions to mainly nuclear in DEM treated neurons. Since the 
cytoplasmic localisation of HDAC4/5 requires the phosphorylation of conserved serine 
residues, the phosphorylation status of HDAC5 was investigated by western blotting. 
This was performed using a phospho-specific antibody that detects phosphorylated 
serine 259 on HDAC5 (and p-246 on HDAC4) (see section 2.3). Cortical neurons, 14 
days in vitro, were treated for 3 hours with either 50 µM Bic/4AP, 10 µM DEM, 100 µM 
DEM or left untreated (control).  
After treatment, the cells were lysed in 1 x RIPA buffer (see section 2.2) and a western 
blot protocol (see section 2.4) was performed with primary antibodies against HDAC5 
and phospho-HDAC5 (p-259). The bands from this western blot are shown in Figure 17A 
where the bands were analysed using the gel analyser tool in ImageJ, and relative 
densities plotted. The phospho-HDAC5 relative densities plotted are normalised to their 
respective inputs of total HDAC5 in the same treatment.  
Compared to the control, all treatments appear to have very similar band densities for 
total HDAC5 indicating that the inputs were all the same (Figure 17A). The p-HDAC5 
band after Bic/4AP treatment shows a stronger signal compared with the control band. 
However, the plotted relative densities show a dose-dependent decrease in the p-259 
band signal, indicating a dephosphorylation, whilst re-probing of the blot with an antibody 















































Figure 17: HDAC5 is dephosphorylated in neurons following DEM treatments. (A) Representative 
western blots of lysates derived from neurons treated as indicated or left untreated (control). All 
treatments were for 1 hour. Blots were probed with antibodies against total HDAC5 (top), p-
HDAC5 (259) (middle) and MEF2D (bottom). (B) Relative densities from analysed phosphorylated 
HDAC5 (p-259) western blot bands are plotted as percentage of total HDAC5 phosphorylated. 
Total HDAC5 bands were normalised to MEF2D bands (shown in A to be unchanged) which was 
used as a loading control. 
 






















Untreated Bic/4AP 10 µM DEM 100 µM DEM 
MEF2D 
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To test if the observed dephosphorylation is a result of changing HDAC5 gene 
expression, a qPCR (see section 2.11) was performed using primers for HDAC4, 5 and 
9. The cDNA was synthesised (see section 2.10) from RNA extracted from rat cortical 
neurons at 14 days in vitro. Relative expressions were compared with neurons treated 
with 50 µM bicuculine and 4-AP or DEM for 1 or 4 hours.  
Figure 18 shows the plotted relative expressions of HDAC4, HDAC5 and HDAC9 under 
these treatments, which show no significant expression changes with 1 hour Bic/4AP 
and DEM treatments. HDAC4 and 9 show no change with 4-hour Bic/4AP treatments. 
However, HDAC5 does have a slight, but not significant, increase in expression (1.68 ± 
0.40-fold change) during these long-term bath applications of Bic/4AP and resulting 
increased synaptic activity, but we cannot confidently conclude whether HDAC5 levels 




















Figure 18: HDAC4, 5 and 9 gene expressions are unchanged in neurons following DEM treatments. 
Representation of relative expressions (RQ) of HDAC4, 5 and 9 from real time quantitative PCR 
experiments. Neurons were treated for 1 hour or 4 hours with the indicated treatments. The 
mean relative expressions from 3 independent experiments are shown. Error bars indicate ± SEM. 
(P>0.05 (ns), one way ANOVA, n = 3 independent cultures).  



























The subcellular localisation of class IIa HDACs is highly dynamic and signal regulated. 
The data in this chapter show that overall oxidative stress conditions cause a nuclear 
accumulation of HDAC4 and HDAC5, suggesting that ROS induce a nuclear 
translocation of class IIa HDACs. There were, however, some notable differences 
between HDAC4 and HDAC5 depending on the mode of ROS induction. HDAC5 shows 
very similar levels of nuclear translocations in both 10 µM DEM and 10 µM paraquat 
oxidative stress conditions. HDAC4, on the other hand, was nuclear in neurons treated 
with DEM but cytoplasmic in those treated with paraquat. Moreover, HDAC4 showed a 
punctate localisation in many neurons. Further experiments could explore visualising 
GFP-tagged HDAC4/5 nucleocytoplasmic shuttling in live cells over time with DEM and 
paraquat treatments. This could identify how long after treatment these HDACs start to 
shuttle to the nucleus, helping to elucidate a timeline for the mechanism.   
HDAC4 has previously been shown to be largely, but not exclusively, cytoplasmic during 
basal conditions in mouse brains (Mielcarek et al., 2013; Bolger & Yao, 2005). This is 
consistent with our findings of HDAC4 being localised to both the cytoplasm and nuclei 
under control conditions, where the percentage of neuronal cells with HDAC4 
cytoplasmic localisation is high. Previous work has shown that a cytoplasmic localisation 
of HDAC4 in untreated neurons is due to spontaneous electrical activity (Chawla et al., 
2003). Increasing synaptic activity further with Bic/4AP is therefore expected to amplify 
the cytoplasmic shuttling of HDAC4. In our findings, Bic/4AP makes HDAC4 adopt an 
even more cytoplasmic distribution, especially when compared with HDAC5 under the 
same conditions. This cytoplasmic distribution bias also explains the less marked nuclear 
translocation change of HDAC4 with DEM treatments.  
The largely cytoplasmic localisation of HDAC4 in neurons under normal conditions could 
be due to a basal phosphorylation level, where the calcium dependent kinases may have 
a low threshold for activation. Findings suggest that the CamKII kinases specifically 
phosphorylate HDAC4 but not HDAC5 (Backs et al., 2006). Moreover, the nuclear export 
of HDAC4, but not HDAC5, is shown to be triggered by spontaneous electrical activity 
(Chawla et al., 2003). Therefore, it could be postulated that these kinases could be 
activated by spontaneous electrical activity alone. Treatment with Bic/4AP, which 
increases neuronal firing, may additionally activate other kinases including CamKIV 
which acts on both HDAC4 and HDAC5. Alternatively, differences in HDAC4 and 5 
structural domains and phosphorylation sites may mean that HDAC4 acts as a less 
optimal substrate for the action of phosphatases which induce their nuclear import.   
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Interestingly, both HDAC4 and 5 show a slight increase in cytoplasmic localisations with 
treatments of Bic/4AP and 10 µM DEM combined compared with Bic/4AP alone where 
these stimuli usually cause opposing translocations. This indicates that the DEM 
oxidative stress condition does not inhibit HDAC nuclear export, but activates an 
independent pathway to drive their nuclear import. It can be postulated that the 
neuroprotective effects of Bic/4AP signals, and subsequent cytoplasmic distributions of 
the HDACs, may be enough to combat conditions of low oxidative stress. Furthermore, 
this low DEM dose seems to accentuate the shuttling towards the cytoplasm for both 
HDAC4 and HDAC5.  
With respect to paraquat-induced oxidative stress, HDAC4 and 5 do not share the same 
pattern of translocation as with DEM. HDAC5 has a very similar nuclear shuttling in 
response to paraquat and DEM, suggesting that the oxidative stress-induced mechanism 
causing its nuclear translocation is active under both these treatments. In contrast, 
HDAC4 shows a dose-dependent shuttling into the cytoplasm with paraquat treatment, 
although not to the same level as the Bic/4AP positive control. It is likely HDAC4 nuclear 
shuttling under DEM conditions is regulated by the same mechanism that controls 
HDAC5 nuclear shuttling, but this raises questions about paraquat’s mode of action and 
cellular effects. Recent, unpublished data from the Chawla lab indicates that paraquat 
treatments can cause low amplitude oscillatory calcium bursts in cultured neurons. 
These low amplitude oscillations might be sufficient to activate a HDAC4 kinase such as 
CamKII, but not HDAC5 kinases. The mechanism by which paraquat causes Ca2+ 
release could be related to its previously reported effects on calmodulin stimulated 
plasma membrane Ca2+-ATPase (PMCA) (Zaidi et al., 2009).  
Resulting increases in intracellular calcium levels in neuronal cells is a known signal for 
the nuclear export of HDAC4 (see section 1.4), where this signal appears to work more 
strongly than the opposing mechanism driving its nuclear import during DEM treatments. 
As discussed previously, cytoplasmic HDAC4 is neuroprotective (Majdzadeh et al., 
2008), and therefore it could be interesting for this calcium burst signal to be exploited 
from a therapeutic point of view. This could drive neuroprotective cytoplasmic HDAC4 
movements, even when neuronal cells are under conditions of elevated ROS levels and 
oxidative stress so common in disease.  
Under high concentrations of paraquat, punctate immunoreactive signals were seen for 
both HDAC4 and HDAC5. This could be due to the neuronal cells being apoptotic in such 
extreme oxidative stress conditions. If this is the case, TUNEL staining could be 
performed to identify if the cells are undergoing apoptosis in these conditions. However, 
the NeuN stain do not appear to have these same puncta, suggesting this change is 
HDAC4/5 protein specific. Moreover, there is no apparent nuclear shrinking or blubbing 
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of the stained nuclei which is indicative of cells undergoing apoptosis. Alternatively, this 
could be due to the HDACs moving into other functional compartments (Takase et al., 
2013). Previous studies observed distinct dot-like structures of GFP tagged HDAC4 in 
HeLa cells (Miska et al., 1999), thought to co-localise with MEF2A, and YFP tagged 
mouse HDAC5 in CV-1 cells, thought to co-localise with mouse HDAC7 in subnuclear 
compartments (Kao et al., 2000). In 2010, Darcy et al. found that HDAC4 
immunoreactivity is punctate in the cytoplasm of neuronal cells across the whole of the 
mouse brain. In addition, some of these observed puncta were seen around the 
cytoplasmic surface of the nuclei, where some were present in dendritic spines (Darcy 
et al., 2010). This was similarly seen in the presented images (Figure 16) where HDAC4 
immunoreactive puncta was perinuclear. Whilst it is unclear what specifically these 
puncta represent, their presence may suggest that the class IIa HDACs may move into 
these functional compartments and co-localise with other proteins.  
It has previously been shown that, in response to high ROS levels, class IIa HDACs are 
subject to different post-translational modifications. Recently, evidence has emerged that 
specific cysteine residues, Cys 667 and Cys 669 on HDAC4 (Figure 4), are oxidised in 
response to oxidative stress in cardiomyocytes, where these redox sensitive cysteines 
are conserved in all class IIa HDACs (Ago et al., 2008). Whilst the irreversible oxidation 
of proteins via ROS can lead to their dysfunctionality, the reversible oxidation of cysteine 
residues on proteins can contribute to the regulation of enzymatic activity, interactions, 
localisation and signalling cascades (Van der Reest et al., 2018). This indicates that the 
class IIa HDACs may undergo a number of post-translational modifications during 
oxidative stress conditions that may contribute to their mechanism of shuttling and action.  
As of yet there has been no specific evidence or research on these class IIa HDAC 
cysteine oxidations when neuronal ROS levels are excessive. Pull down experiments 
were attempted under normal and DEM-induced oxidative stress conditions using 
biotinylated-iodoacetamide, an agent that binds free thiol levels. These experiments 
aimed to detect free thiol levels and therefore oxidation modifications (where free thiol 
levels went down) in HDAC5 under these conditions. Whilst attempts were not successful 
in yielding a reliable result, this would be an interesting future approach. This would help 
in the understanding of how the class IIa HDACs are modified under oxidative stress 
conditions in the brain, and how their modifications may contribute to or affect their 
mechanisms of action. 
Two phospho-HDAC5 antibodies (p-259 and p-498 phosphorylation sites) were used for 
immunostaining sets of treated cortical neurons in the same way as HDAC4 and HDAC5. 
However, it was deemed that these antibodies were not specific enough in the context 
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of visualising the fluorescent signals by confocal microscopy as they appear to represent 
the location of HDAC5 rather than actual phosphorylated HDAC5.  
From these images, it was also not possible to deduce if a dephosphorylation was 
occurring. Thus, western blots were used instead for these investigations, which 
displayed a likely dephosphorylation of HDAC5 under DEM conditions, supporting our 
previous findings of a HDAC5 nuclear translocation. As discussed in section 1.4, the 
dephosphorylation of the class IIa HDACs by phosphatases (such as PP2A) is a key part 
in their nuclear import. This result was corroborated by qPCR data which showed no 
significant changes in HDAC5 gene expression with DEM treatments, in line with the 
observed similar band densities for total HDAC5. Together, these findings indicate that 
the decrease in phospho-HDAC5 levels detected in the western blot was not due to 
decreases in overall HDAC5 gene expression. However, the HDAC5 dephosphorylation 
data was from one experiment and would therefore require repetition.  
In addition, a slight upregulation of HDAC5 after long (4-hour) treatments with Bic/4AP 
was observed. The statistics revealed no significance in the change in HDAC5 levels in 
this condition, however if HDAC5 expression is increasing, this could help to explain the 
slight increase in total HDAC5 and phospho-HDAC5 levels in Figure 17. An important 
role for HDAC5 in the detoxifying antioxidant mechanisms is therefore suggested, 
triggered by increases in neuronal firing. Further experiments could be performed to 
investigate why HDAC5 might be transcriptionally upregulated after these long periods 
of high synaptic activity, and what it might be interacting with in the cytosol. The HDAC5 
localisation changes were seen after 2-hour treatments with Bic/4AP in this study, and 
previous studies demonstrated the same increase in cytoplasmic HDAC5 after 1 hour. 
Therefore, it would be appropriate to repeat the experiment with a 4-hour Bic/4AP 
treatment to determine if HDAC5 is still retained in the cytoplasm at this point.  
Nucleocytoplasmic fractionations were attempted during the project with neurons treated 
similarly to the neurons used for the localisation data, and the samples ran on a western 
blot. The western blot approach was not sensitive enough to pick up the lower levels in 
each fraction compared to whole cell lysates. However, additional experiments could re-
attempt this to support the findings of HDAC4 and 5 shuttling under DEM treatments.  
In addition, this fractionation technique could be used to confirm the observation of a 
slight increase in HDAC5 expression after Bic/4AP treatment. This may be attempted 
using buffers of different stringencies (e.g. soft lysis and RIPA buffers) to fractionate out 
nuclear and cytoplasmic samples. Immunoprecipitation (IP) techniques could then be 
used on these fractionated samples to explore interactions of HDAC5 in the cytoplasm 
during bouts of increased neuronal activity. If these techniques are not sensitive enough 
to pick up the interactions, proteomics screens may prove beneficial.   
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4. Interactions of class IIa HDACs in the nucleus  
This chapter aims to investigate the impact of the oxidative stress-induced nuclear import 
of HDAC4/5 on gene regulation by assessing mRNA levels of putative HDAC4/5 target 
genes. This chapter includes the findings that the genes Spp1 and Tpm2, both with links 
to CNS related disease, are likely upregulated specifically in neuronal cells following 
treatments with low doses of DEM. This correlates well with the nuclear imports of 
HDAC4/5 under the same conditions, and was found to be most significant with short, 1-
hour treatments. Treatments of the same neuronal cells with TTX, an agent which blocks 
synaptic activity, also showed a possible induction of the Tpm2 gene, whilst Bic/4AP, 
which increases synaptic activity, saw a likely Tpm2 repression. Together, these findings 
suggest that the Spp1 and Tpm2 genes may be induced under oxidative stress 
conditions through nuclear HDAC4/5 activation of FOXO transcription factors. 
Additionally, the Gadd45 gene, implicated in DNA damage repair and protective 
pathways in the brain, was found to possibly be induced in wildtype flies and flies 
expressing mammalian GFP tagged HDAC5 raised on DEM food. Images from brain 
dissections of the same flies expressing GFP-HDAC5 show a possible nuclear 
translocation of the expressed HDAC5 under oxidative stress conditions. This, together 
with sequence alignments of the Gadd45 gene promoter in flies, rats and humans 
suggest a conserved mechanism of Gadd45 regulation by HDAC4/5. Therefore, these 
findings could translate into the human brain. 
4.1. A group of genes is induced under oxidative stress conditions in neurons 
Following on from the observation of the oxidative stress-induced nuclear import of 
HDAC4 and 5, it was important to explore their subsequent impact on gene regulation to 
help identify mechanisms which may be occurring under these conditions.  
In 2012, Sando et al. investigated differentially expressed genes in the mouse forebrain 
with a constitutively nuclear HDAC4 mutant (3SA) compared to wildtype HDAC4. This 
mutant substituted alanine residues for key serine phosphorylation sites. This ensured 
the chaperone protein 14-3-3 could no longer bind and sequester the HDAC4 mutant in 
the cytoplasm (Sando et al., 2012). Within their DNA microarray data, the nuclear 3SA 
mutant was shown to repress a large array of genes, as well as induce a small gene 
group compared to the wildtype. As class IIa HDACs have been shown to activate FOXO 
transcription factors (Mihaylova et al., 2011) it is possible that the 3SA mutant in Sando 
et al. is acting via FOXO. Experiments reported in the previous chapter show that DEM 
caused a nuclear localisation of HDAC4/5. This chapter therefore investigated whether 
DEM increases transcription of the genes that are upregulated by a constitutively nuclear 
HDAC4 mutant.  
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Table 10 displays some of the genes that were induced with the greatest fold change in 
the 3SA mutant over wildtype (Sando et al., 2012). This, therefore, identified them as 
genes of particular interest in this study.   
Table 10. List of genes induced with the 3SA HDAC4 mutant compared with wildtype and their 
relative fold changes (Sando et al., 2012). 







Among these genes is secreted phosphoprotein 1 (Spp1), which encodes the protein 
osteopontin (OPN) and is a constituent of the extracellular matrix of the central nervous 
system (CNS). Spp1 has been found to be upregulated in microglia (Yu et al., 2017), and 
is hypothesised to have a role in the pathogenesis of neurodegenerative diseases such 
as Alzheimer’s (Wung et al., 2007).   
Tropomyosin 2 (Tpm2) encodes beta-tropomyosin, an actin-filament binding protein 
which is mainly functional in skeletal muscles. Despite this, actin dynamics are beginning 
to be identified as playing key roles in neural development (Kumar et al., 2016). Whilst 
the precise role of actin binding proteins in nervous system development remains 
unknown, recent studies demonstrated that knockdown of Tpm2 expression leads to 
impaired spatial learning and memory performance in the rat hippocampus (Hsu et al., 
2017).  
Like Tpm2, moesin (Msn) is an actin binding protein and has been found to restrain 
synaptic growth in flies (Seabrooke & Stewart, 2008) and is elevated in the visual cortex 
of sensory deprived mice (Tropea et al., 2006).   
Growth arrest DNA damage-inducible protein (Gadd45) is involved in DNA damage 
repair and is a known FOXO target gene. The Gadd45 gene has been shown to be 
induced in cases of Alzheimer’s disease (Torp et al., 1998) and implicated in apoptosis 
and protective pathways against stress in the brain (Moskalev et al., 2012).  
The upstream transcription factor 1 (Usf1) gene encodes for a ubiquitously expressed 
transcription factor known to regulate diverse functions (Yamanaka et al., 2016) including 
stress responses (Corre & Galibert, 2005). However, their role in the brain remains 
unclear. As described in section 1.5, Txnip is a FOXO target gene and an oxidative stress 
sensor part of the protective redox control system in the brain. 
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In this study, these genes were investigated in both rat cortical neurons and transgenic 
Drosophila to evaluate conserved mechanisms involving the class IIa HDACs under 
oxidative stress conditions between fly and rat brains.   
In order to examine whether these genes had altered gene expression under conditions 
of oxidative stress, quantitative PCRs were performed. Cortical neurons in culture at 14 
days in vitro were left untreated (control) or treated for 1 or 4 hours with either Bic/4AP, 
which causes cytoplasmic translocation of HDAC4/5, or 10 µM DEM, which induces 
HDAC4/5 nuclear import. Tetrodotoxin (TTX) treatment was included for comparison as 
silencing of neuronal activity with TTX also results in a nuclear localisation of both 
HDACs (Chawla et al., 2003).  
RNA was extracted from these treated neurons (see section 2.8), subjected to cDNA 
synthesis (see section 2.10) and qPCRs (as in the protocol in section 2.11) were 
performed with the primers as set out in Table 9.  

















































Figure 19: Oxidative stress conditions upregulate Tpm2 and Spp1 gene expression in neurons. 
Neurons were treated for 1 hour or 4 hours with the indicated treatments. Representations of 
relative gene expressions (RQ) are plotted for Tpm2 (dark blue), Spp1 (light blue) and Txnip (pale 
blue). Gapdh was used as the housekeeping gene. The mean relative expressions from 2-4 
independent experiments are shown. Error bars indicate ± SEM where n = 3 or more. (P<0.001 
One way ANOVA followed by Dunnett’s post-hoc test *P<0.005 ****P<0.0001).  
As shown in Figure 19, the Tpm2 gene in neurons showed both induction and repression 
of expression under different treatments. A highly significant (p<0.0001) induction of 
Tpm2 expression (12.8 ± 3.0-fold change) was observed following 10 µM DEM 
treatment, where this change was much stronger after 1 hour compared to a slight, but 
not significant, induction after 4 hours (1.5 ± 0.30-fold change). Conversely, a repression 
of Tpm2 was observed following Bic/4AP treatment, with a more marked change seen 
within 1 hour (0.16 ± 0.06-fold change) compared to 4 hours (0.59 ± 0.22-fold change) 
(Figure 19). Treatment with TTX showed a slight induction of Tpm2 expression (1.2 ± 
0.18-fold change).  
Results indicated no significant changes in Spp1 relative expression after 4-hour 
treatments with 10 µM DEM, TTX or any Bic/4AP treatments. However, 1-hour 
treatments with 10 µM DEM did show an induction of the Spp1 gene in cultured rat 
neurons (2.16 ± 0.09-fold change) (Figure 19). Whilst no significant changes were found, 















































































































































the Spp1 relative expressions seemed to follow similar patterns to Tpm2, where after 4 
hours 10 µM DEM treatments, Spp1 showed a smaller possible induction (1.44 ± 0.14-
fold change) than 1 hour, and TTX showed an even smaller possible induction (1.28 ± 
0.09-fold change). Finally, Spp1 may cause a very small (and therefore not significant) 
repression after 1 hour Bic/4AP treatment (0.86 ± 0.54-fold change) as found with Tpm2.  
Results for the Txnip gene show insignificant changes across all treatments of 1-hour 10 
µM DEM, Bic/4AP and TTX treatments. Interestingly, Txnip also followed the same 
pattern as Tpm2 and Spp1, with the biggest induction following 10 µM DEM treatments 
(1.41 ± 0.49-fold change), a smaller change with 4 hours 10 µM DEM (1.35 ± 0.26-fold 
change), and even less so with 4-hour TTX treatments (1.21 ± 0.09-fold change). 
However, Bic/4AP bath application does not appear to show any repressive activity on 
Txnip in neurons (0.925 ± 0.43-fold change, 1.185 ± 0.30-fold change for 1- and 4-hour 
treatments respectively). 
Overall, the most marked changes in relative expressions were observed in the relative 
order of Tpm2, Spp1 and Txnip. All three genes followed similar patterns over time and 
treatments and notably all three genes are induced by 10 µM DEM treatments and could 






































Figure 20: A heatmap of putative transcription factor binding site hits for selected genes of 
interest. FOXO1, 3 and 4, AP-1, MEF2 and HIF1A transcription factors were searched with Txnip, 
Tpm2, Spp1, Msn, Gadd45a and Usf1 genes on the LASAGNA 2.0 search tool for transcription 
factor binding sites. Hits with p<0.005 were considered putative, where FOXO1, 3 and 4 were 
combined into a general FOXO family group. The putative hits were compiled and plotted as a 
heatmap for each gene and the number of hits for a specific transcription factor family. Scale bar 
ranges from least number of hits in black up to the greatest number of hits in light yellow.  
The LASAGNA 2.0 search tool identifies and visualises transcription factor binding sites 
(Lee & Huang, 2013) through inputting a list of selected transcription factors and target 
genes. A heatmap of the putative hits for each transcription factor family among a group 
of genes of interest was plotted in Figure 20, where putative hits were defined as those 
with p values <0.005. The number of hits within that threshold were counted and plotted 
for the individual genes. Activator protein 1 (AP-1) is a transcription factor that controls 
many processes including cell proliferation, differentiation, survival and apoptosis 
(Shaulain & Karin, 2001). The AP-1 transcription factors have been implicated 
specifically in oxidative stress where they are induced in response to hydrogen peroxide 
(Jawed et al., 2000). Hypoxia inducible factor 1 alpha (HIF1A) is a stress inducible 
transcription factor which is thought of as a master regulator in adaptive cellular 
responses to hypoxia (Semenza, 1998). This heatmap reveals that this gene group have 
more putative hits for FOXO factors, and are more likely regulated by these transcription 
factors compared to AP-1, MEF2 or HIF1A factors.  












4.3. Gadd45 is upregulated in Drosophila under oxidative stress conditions 
 
At present, no primary antibodies for Drosophila HDAC4 are available for use in 
immunohistochemistry techniques to directly compare with HDAC4/5 in cortical neurons. 
Instead, transgenic flies expressing mammalian HDAC5 fused to GFP were used. Figure 
21 shows sequence alignments of Drosophila HDAC4, human HDAC4 and HDAC5 
protein sequences for key domains and residues including serine residues required for 
14-3-3 binding. This demonstrates high protein conservation between the Drosophila 
HDAC4 and human HDAC4 and 5, and thus it would be logical for this conservation to 
















Figure 21: Sequence alignment of protein sequences for Drosophila HDAC4, human HDAC4 and 
human HDAC5. Shaded in grey are sequences of identical, highly conserved residues. Arrows 
indicate important residues for MEF2, calmodulin and phosphorylation sites for 14-3-3 binding as 
well as key sites in the nuclear localisation signal (NLS). “*” indicates residues in that column are 
identical between all three species. “:” indicates that conserved substitutions are observed and 
“.” Indicate that semi-conserved substitutions are observed. Where conserved is described as the 
residue being substituted with one that has similar characteristics. Sequence alignments were 
performed using the Clustal W tool (Larkin et al., 2007). 
Experiments were designed to test from the same group of genes (Table 10), where a 
fly orthologue was known, and investigate any changes in their gene expressions under 
oxidative stress conditions. Thus, we can directly compare the class IIa HDAC 
mechanism seen in neurons with that in flies. The Drosophila genetic crosses designed 
to express GFP tagged mammalian (human) HDAC5 in neurons only were set up (as 
MEF2 
P 
NLS DAC NES 
P 
14-3-3 14-3-3 
247 DFPLRKTASEPN 259 
236 DFPLRKTASEPN 249 
251 DFPLRKTASEPN 263 
    ************ 
581 HRPLGRTQSAPLP 594 
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249 LKLRSRLKQKVAERRSS---PLLRRKDGPVVTALKKRP 300 
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172 CSANASPEVKQILNCFILSRKSQAAASNGT 202 
162 ESAVASTEVKMKLQEFVLNKKKALAHRNLN 192 
175 ESAIASTEVKLRLQEFLLSKSKEPTPGGLN 205 













described in section 2.1) and given a diet of food containing either ethanol (EtOH) or 
DEM for a period of either 3 days or 1 week.  
RNA was extracted from the frozen whole flies with the protocol as set out in section 2.9, 
and cDNA was synthesised as described in section 2.10.  
qPCRs were performed with primers designed for the Drosophila orthologs of USF1 
(dUsf), Msn (dMoe) and Gadd45 (dGadd45) as set out in Table 9.  
















































Figure 22: The Drosophila Gadd45 gene is likely induced in flies raised on DEM food and in flies 
expressing a constitutively nuclear HDAC5 transgene. Flies expressing GFP alone (EGFP), GFP 
tagged human HDAC5 (HD5) or a GFP tagged nuclear mutant human HDAC5 (DM) were raised 
and maintained on food containing ethanol or DEM for 3 days to 1 week as indicated. 
Representation of relative expressions plotted for the Drosophila Gadd45, Usf and Moe genes. 
Rpl1 was used as a housekeeping gene and expression is relative to gene expressions of the genes 
in control EGFP flies raised on EtOH containing food. RNA was extracted from 10 to 20 whole flies 
in each condition. n = 1 for all conditions except HD5 DEM 1 wk, which is n = 2.  
As shown in Figure 22, the Gadd45 gene in Drosophila appears to be induced across all 
the fly genotypes and foods compared to control. The most significant induction for the 
HDAC5-GFP flies was seen after 1 week on DEM food (4.63 ± 3.5-fold change), where 
these flies already showed dGadd45 induction on ethanol food (3.37-fold change). The 
mutant HDAC5-DM flies saw a marked increase in Gadd45 expression on all treated 
foods, with the most significant change seen after 1 week on ethanol food (2.6-fold 
change) compared to DEM foods (1.76- and 1.87-fold changes respectively).  
The Usf gene in Drosophila showed no significant changes in relative expression, except 
in the HDAC5-GFP flies left on ethanol (2.07-fold change) and DEM food (1.54-fold 
change) for 1 week. The same HDAC5-GFP flies on DEM food for 3 days did not show 
any significant induction (1.19-fold change) of the dUsf gene (Figure 22).  
The Moe (moesin) gene in Drosophila showed no significant changes in relative 
expression in any of the fly genotypes or treatments (Figure 22). 
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4.4. Dissection of Drosophila brains expressing GFP tagged HDAC5 show a possible 
conserved nuclear translocation  
 
Given the conservation of phosphorylation sites that regulate HDAC4/5 localisation (as 
shown in Figure 21), it is expected that the signalling mechanisms are also conserved. 
The localisation of human HDAC5-GFP in response to DEM treatment was therefore 
investigated in transgenic flies.  
After setting up the genetic crosses, as set out in section 2.1, to drive neuronal 
expression of mammalian GFP tagged HDAC5 in transgenic Drosophila, the F1 
generation progeny were tested for GFP expression. After collection, the progeny were 
frozen, the heads removed and lysed in either 1 x RIPA buffer or 2 x SDS sample 
buffer as stated in section 2.2. These samples were run on a western blot (see section 
2.4) with an antibody against GFP (see section 2.3 for antibody details). Figure 23 
shows the resulting western blot confirming GFP expression within all the Drosophila 
cross genotypes. However, the mutant DM flies appear to display much lower GFP 











Figure 23: Western blot scans confirming GFP expression in brains of transgenic Drosophila. 
Lysates from Drosophila heads expressing either GFP tagged wildtype HDAC5 (HD5) or GFP tagged 
double mutant HDAC5 (DM) were ran on a western blot with a polyclonal antibody against GFP. 
10 fly heads per genotype were lysed in either 1 x RIPA or 2 x SDS buffer and samples ran on a 

























Figure 24: A possible nuclear translocation of expressed GFP tagged human HDAC5 is observed 
in the brains of transgenic Drosophila raised on DEM food. Flies expressing GFP tagged human 
HDAC5 or a GFP tagged nuclear mutant HDAC5-DM were raised and maintained on food 
containing ethanol or DEM for 1 week as indicated. Representative confocal images of GFP 
fluorescent signals from (A) HDAC5-GFP flies on ethanol food, (B) HDAC5-GFP flies on DEM food 
and (C) HDAC5-DM mutant flies on ethanol food. Images taken at x64 objective. Scale bar = 35 
µm. 
Figure 24 shows representative confocal images of GFP fluorescent signal taken from 
dissected fly brains expressing HDAC5-GFP and HDAC5-GFP-DM nuclear mutant flies 
raised on EtOH or DEM food for 1 week. As described in section 2.1, an nSyb115 neuronal 
driver was used to drive neuronal specific expression of the GFP tagged wildtype and 
mutant forms of HDAC5 in Drosophila. Neuronal synaptobrevin (nSyb) is thought to be 
expressed in all neurons (but not other cell types) (Davis et al., 2020) and its promoter 
region has been used to generate a pan-neuronal driver for Drosophila. This genetic 
driver has been shown to be specific for neurons (Zhao et al., 2020) and it therefore was 
assumed that there was no expression outside of neuronal cells. 
The HDAC5-GFP signal is quite dispersed and generally localised to the neuronal cells 
in the dissected Drosophila brains on EtOH control food (Figure 24A). With the same 
flies, the HDAC5-GFP signal appears to be more localised after 1 week on DEM food 
(Figure 24B). The HDAC5-GFP-DM mutant flies, which are constitutively nuclear, also 
show this localised fluorescent signal (Figure 24C). This acts as a positive control for the 
nuclear accumulation of the expressed human HDAC5 in the Drosophila neuronal cells.  
Despite this, there was no staining for the neuronal cells performed, as done in section 
3.1 in cultured rat neurons. This therefore would be an important step to add if this 
experiment was repeated in order to confirm the movement of HDAC5-GFP and that the 
images display neuronal cells.  
HDAC5-GFP EtOH  HDAC5-GFP DEM HDAC5-DM EtOH 
A B C 
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4.5. The Gadd45 gene is largely conserved among species 
 
To further investigate whether Gadd45 could be regulated by HDAC4/5 and FOXO, an 
in silico approach was used to look for FOXO putative binding sites in the Gadd45 gene 
promoter. The LASAGNA web tool (Lee & Huang, 2013) was used to find FOXO binding 
sites in the Gadd45 gene from different species. Sequence alignments of the Gadd45 
gene promoter in different species is shown in Figure 25. This displays a forkhead 
binding element (FBHE) coloured in red in the Drosophila Gadd45 gene which is shown 
to be largely conserved amongst the Gadd45a genes in other species, including those 






Figure 25: Sequence alignments of the Gadd45 gene promoter in different species. Drosophila 
Gadd45 and human, rat and mouse Gadd45a promoter genomic sequences are aligned. Highly 
conserved sequences are highlighted in grey. Coloured in red is a forkhead (FOXO) binding 
element shown to be largely conserved. Positions indicated are in relation to the transcriptional 
start sites and beginning of the promoters. “*” indicates residues in that column are identical 
between all three species. Sequence alignments were performed using the Clustal W tool (Larkin 
















dGadd45  1198 CAGAACCATACATAAATATAGCCAATTT--GTTTC-------------TGT 1234 
hGadd45a 1691 CAGGGCAG--ATTAGATAAAGCCAAATGAATT-CCTGGCTCACCCCTCATT 1739 
rGadd45a  931 CAGAACAG--ATTAGATAAAGCCACATTAAGTTCCCGGTTCACCCTTCGTT 980 
mGadd45a  939 CAGAACAG--ATTAGATAAAGCCAAATA-AATTCCCGGTTTACCCTTCGTT 987 




No study of the role of class IIa HDACs under neuronal oxidative stress could be 
complete without investigation of their epigenetic influence. OPN (encoded by Spp1) has 
been found to be upregulated in human AD brains, where it was shown to localise to 
neurons already vulnerable to death (Wung et al., 2007). It was postulated that OPN 
plays a role in the prevention of apoptosis and the promotion of cell proliferation as a 
response to neurodegeneration in these cases. Studies in rats also found increased OPN 
expression in neurons after brain trauma (Shin et al., 2005) and it appears to have a 
protective role against nitric oxide (NO)-induced oxidative damage in the aging human 
brain (Wung et al., 2007). As previously discussed, a novel role for Tpm2 has recently 
been suggested in learning and memory formation in the rat hippocampus (Hsu et al., 
2017) which may be indicative of further roles for Tpm2 in the brain.  
The results from qPCRs with cDNA from treated neuronal cells show an induction of 
Spp1 and Tpm2 after 10 µM DEM treatments, which correlates well with the observed 
nuclear import of HDAC4 and 5 under the same conditions. Tpm2 and Spp1 both showed 
significant inductions with short, 1-hour treatments of 10 µM DEM compared to 4-hour 
treatments, suggesting that this mechanism happens in a relatively short time frame.  
Inductions of their gene expressions were still seen after 4 hours of DEM treatment, albeit 
not to the same extent, suggesting that this mechanism is most active up to 1 hour and 
gradually dissipates over time. These changes were observed in cultured cortical 
neurons with 1-day in vitro cytosine arabinoside (AraC) treatment, which inhibits non-
neuronal cells. Experiments with the same treatments in the neurons after 4-days in vitro 
AraC treatment (indicative of more astrocytes) did not show the same significant changes 
(data not shown). This therefore suggests that these changes are neuronal specific and 
do not occur in astrocytes or microglia.  
4-hour TTX treatments (designed to block synaptic activity) also showed some induction 
of the Tpm2 gene, however this was below the change seen with 4-hour 10 µM DEM 
treatments. On the other hand, Bic/4AP (which increases synaptic activity) caused 
repression of Tpm2 where a stronger change was seen within 1-hour compared to 4-
hour treatments, suggesting the mechanism of its repression also happens on a similar 
short time scale.  
As DEM and TTX treatments are shown to cause a nuclear translocation of the class IIa 
HDACs in rat cortical neurons, it can be hypothesised that Spp1, Tpm2 and, to an extent, 
Txnip genes are induced after the movement of these HDACs into the nucleus. Their 
subsequent activity, perhaps through binding to and activation of FOXO transcription 
factors, could therefore lead to these genes being upregulated. Supporting this, NMDAR 
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blockades are shown to upregulate Txnip expression in rat neurons (Papadia et al., 
2008). These genes are indicated as having the same or even more putative hits 
compared to the known FOXO targets Txnip and Gadd45 when interrogated for 
transcription factor binding sites (Figure 20). Therefore, they are likely to be similarly 
regulated by these FOXO factors. 
Alternatively, signals such as Bic/4AP treatments (which cause class IIa HDAC 
cytoplasmic movements) may cause repressions of Tpm2 as they are no longer able to 
bind and regulate FOXOs in the nucleus. The changes seen are neuronal specific and 
most significantly occur with short treatments of low DEM doses, suggesting this 
mechanism is working quickly to combat the oxidative stress state. This supports 
previous findings where the Spp1 encoded protein OPN is upregulated in human and rat 
brains where neurodegeneration is present, and the postulations that it has a protective 
role against oxidative stress.  
The Gadd45 gene is well known to be implicated in protective mechanisms, and 
specifically D-GADD45 overexpression has been found to increase stress resistance in 
(Moskalev et al., 2012) and lifespan of Drosophila melanogaster. In the same study, D-
GADD45 expression was also increased in wildtype flies exposed to different stress 
factors, demonstrating its protective role in flies. Oxidative stress was also shown to 
increase Gadd45a mRNA in a mouse model, indicating a similar role in mammals 
(Furukawa-Hibi et al., 2002).   
As seen in Figure 22, the Gadd45 gene in Drosophila is shown likely to be induced in 
the EGFP control flies by DEM as well as being likely upregulated in the HDAC5-GFP 
and HDAC5-DM mutant flies on both EtOH and DEM foods. Expression of mammalian 
HDAC5 in the flies seems to somewhat increase the dGadd45 gene expression even in 
the absence of oxidative stress conditions. The possible inductions seen under DEM 
conditions appear to be even more marked, suggesting that the dGadd45 gene may be 
induced due to the shuttling of the expressed HDAC5 into the nucleus in fly neurons, 
similar to investigations in the rat brain.  
The observation of a larger possible induction of Gadd45 seen in EGFP control flies 
raised on DEM suggests this shuttling is also happening for Drosophila HDAC4, where 
a conserved mechanism between rat and fly class IIa HDACs may be occurring under 
the oxidative stress state. The likely upregulation also supports previous findings of its 
protective role and upregulation during stress stimuli in flies. Interestingly, the 
constitutively nuclear DM mutant flies showed the highest increase when raised on 
ethanol control food and a similarly lower induction of the dGadd45 gene after both 3 
days and 1 week on DEM food. This could indicate that this gene is possibly induced on 
a short timescale with the presence of nuclear HDAC5. With further applications of DEM 
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and prolonged nuclear HDAC5, the upregulation of dGadd45 gene expression could be 
reduced, with the nuclear cells perhaps becoming apoptotic. However, this data is from 
a single experiment and needs to be repeated.  
In the same experiment, the Drosophila USF1 ortholog (dUsf) showed similar changes 
in mRNA levels. The qPCR results indicated that the Drosophila dUsf gene was likely 
upregulated in the HDAC5-GFP flies, where this change after 3 days on DEM food was 
smaller compared to EtOH food. Therefore, this suggests that the transgenic expression 
of HDAC5 may upregulate dUsf, especially in the absence of stress stimuli. This could 
further suggest a possible physiological role for USF1 in rat and human brains under 
normal conditions, where any upregulation is prevented during oxidative stress.  
Western blots of the F1 progeny lysates from the Drosophila crosses (as described in 
section 2.1) confirmed GFP expression in all the genotypes, although it was observed 
that lysates of HDAC5-DM mutant flies showed less GFP signal than the HDAC5-GFP 
fly lysates (Figure 23). Brains dissected from the F1 progenies revealed a possible 
nuclear translocation of transgenic expressed HDAC5, where the GFP signal seems 
more concentrated in HDAC5-GFP flies on DEM food and all HDAC5-DM mutant flies. 
This suggests that the mechanism of the class IIa HDACs shuttling to the nucleus under 
oxidative stress conditions may be conserved between species. However, future 
experiments would be needed with a stain for the nuclei and general neuronal markers 
(as done with rat neurons in section 3.1) to confirm this translocation and observe the 
HDAC5-GFP signal in the context of the Drosophila neuronal cells.  
Sequence alignments of the Gadd45 gene promoter regions in flies, humans, rat and 
mouse indicate a largely conserved FOXO binding site on the gene further supporting a 
conserved mechanism between the species. Whilst many of the key motifs for Drosophila 
HDAC4 are similar to human HDAC4 and 5 (Figure 21), the conservation of transcription 
factor binding sites helps to identify if the regulation of genes such as Gadd45 are 
occurring in the same manner under oxidative stress conditions. Key future experiments 
would include using a Gadd45a primer in qPCR experiments using treated cultured rat 
cortical neurons to explore whether this gene is also induced in the rat brain under the 
same DEM conditions.  
After confirmation of GFP signals by western blotting, pull down experiments were 
attempted to screen for conserved interactors between Drosophila HDAC4 and human 
HDAC5, however this yielded no solid results. Future work could include repetition of 
these GFP pull downs with tweaking of the protocol where necessary. Separation of male 
and female flies in these experiments may also reveal differences in the mechanisms, 
gene expressions or interactions between genders in Drosophila brains.  
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Whilst qPCRs with the Drosophila crosses provided some promising results, this would 
require more repeats to be confirmed and to establish any significant inductions of gene 
expressions in the chosen genes. However, some of the flies raised on DEM food died 
before collection after 1 week, and as such the concentration of DEM in the food may 
need to be reduced to collect large enough sample sizes for these experiments.  
Future experiments would also include a proteomics screen for protein-protein 
interactions with the same Drosophila crosses and genotypes to identify differences in 
their interactions between control, HDAC5 expressing and HDAC5-DM constitutively 
nuclear mutant flies. This would reveal any interactions which are conserved between 
Drosophila HDAC4 and mammalian HDAC5, and specifically what the HDAC5-DM 




























5. Concluding Remarks  
In this study, it was found that the class IIa HDACs 4 and 5 both translocate to the 
nucleus of rat cultured cortical neurons under oxidative stress conditions induced by 
glutathione depletion. HDAC5 was found to likely be dephosphorylated under the same 
conditions, shown previously to be a key step in HDAC5 nuclear import (Greco et al., 
2011) and supporting the finding of its nuclear accumulation. During fasting in the liver, 
these class IIa HDACs are known to shuttle to the nucleus after dephosphorylation to 
activate FOXO transcription factors and boost their target genes (Klotz et al., 2015). In 
addition, a ROS-induced nuclear import of FOXO factors has been established (Van der 
Horst & Burgering, 2007).  
Moreover, the Spp1 and Tpm2 genes showed neuronal specific increases in gene 
expressions after DEM applications, most significantly with short, low dose treatments. 
Tetrodotoxin (TTX) treatments, designed to block synaptic activity through blocking 
voltage gated sodium channels (Geffeney & Ruben, 2006), also led to the induction of 
these genes. Bic/4AP on the other hand, designed to increase synaptic activity, saw 
repressions in a similar time-dependent manner. Observations were made of a possible 
nuclear translocation of GFP tagged human HDAC5 expressed in transgenic Drosophila 
brains. Additionally, the DNA damage repair Gadd45 gene, shown to be part of a stress 
protective mechanism in Drosophila (Moskalev et al., 2012) was found to be likely 
upregulated in flies raised on DEM food. Moreover, in silico techniques revealed a 
conserved FOXO binding site in the promoter regions of Gadd45 between species.  
Therefore, the following conserved mechanism is proposed. An increase in ROS 
species, induced by glutathione depletion (Ugbode et al., 2020), causes both HDAC4 
and 5 to become dephosphorylated by serine/threonine phosphatases. Subsequently, 
they shuttle to the nucleus along with FOXO transcription factors (Figure 26). Once in 
the nucleus, the HDACs bind and deacetylate the FOXOs in association with HDAC3-
NCoR co-repressor complexes. This allows the FOXO transcription factors to 
transactivate genes including Spp1, Tpm2, Txnip and Gadd45. Conversely, increases in 
synaptic activity, induced by bath applications of Bic/4AP, leads to HDAC4/5 cytoplasmic 
translocation and retention. There they are prevented from activating these genes via 
FOXO binding in the nucleus. It is further proposed that this protective mechanism is 
most active up to 1 hour post treatment and may then dissipate over time.  
The mechanisms that lead to the nuclear translocation of the class IIa HDACs under 
oxidative stress conditions remains unknown. However, it is hypothesised that either: (i) 
ROS may inhibit the protein kinases (e.g. CamKII and CamKIV) that phosphorylate the 
HDACs and allow their nuclear export and retention in the cytoplasm (Figure 26) or (ii) 
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ROS may activate the serine/threonine phosphatases (e.g. PP2A), thus 
dephosphorylating the HDACs and causing their nuclear import. It is also possible the 
ROS species may oxidise the class IIa HDACs leading to their inactivation, but this is not 
supported by recent mouse cardiomyocytes studies in which oxidation of HDAC4 after 
oxidative stress induced its nuclear export (Matsushima et al., 2013). However, this may 














Figure 26: Proposed mechanism of HDAC4/5 nuclear import during oxidative stress. Increased 
synaptic activity induced by Bic/4AP bath application causes a Ca2+ influx which activates kinases 
to phosphorylate the HDACs and incites their nuclear exit. Forskolin activates the adenylate 
cyclase enzyme, responsible for the production of cAMP, which in turn activates serine/threonine 
phosphatases which are responsible for the HDACs dephosphorylation and nuclear import. 
Proposed pathways are indicated with dotted lines and include the ROS inhibiting the HDAC 
kinases, activating the phosphatases or oxidising the HDACs to drive their nuclear translocation 
during oxidative stress.  
It is further proposed that, as a protective mechanism, under low conditions of oxidative 
stress and just over the cytotoxic tipping point of the ROS to antioxidant balance, HDAC4 
and 5 move towards the nucleus within one hour to induce Tpm2, Spp1, Txnip and 
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oxidative stress, the neuronal cells become overwhelmed and become apoptotic. 
Nuclear HDAC4 has been implicated in the repression of genes essential for synapse 
health and function (Sando et al., 2012) and in the progression of disease in the brain 
(Fitzsimons, 2015). In addition, the nuclear exclusion of HDAC5 has also been found to 
promote neuronal survival (Linseman et al., 2003). This might suggest that after the initial 
protective mechanism proposed above, the continued nuclear accumulation of the class 
IIa HDACs becomes neurotoxic.  
A link between Drosophila HDAC4 and Alzheimer’s disease has already been found 
(Cao et al., 2008) and therefore, the proposition of a conserved mechanism is of 
importance. Drosophila are shown to be excellent models for neurodegenerative 
disorders (Bolus et al., 2020), where functional sites in Drosophila HDAC4 is highly 
conserved with human HDAC4 and HDAC5 (Figure 21). Concurrent investigations using 
Drosophila and Rattus norvegicus models would be invaluable in any future work based 
on these findings. Eventual thorough understanding of the mechanisms, modifications 
and interactions of the class IIa HDACs in the brain during oxidative stress conditions 
could be translated well to the human brain and used as a foundation for therapeutic 
intervention. 
Previous work indicates that overexpression of the sulfiredoxin (SRXN-1) antioxidant 
gene can rescue morphological neuronal damage due to an ROS burden (Ugbode et al., 
2020). Synaptic activity is also shown to increase SRXN-1 expression (Bell & 
Hardingham, 2011) and in this study increasing synaptic activity led to a protective 
cytoplasmic accumulation of the class IIa HDACs. Therefore, exploiting Ca2+ influx 
signals to induce this neuroprotection during conditions of low oxidative stress may prove 
a promising therapeutic approach in a diseased brain.  
Findings in this thesis, along with findings in the literature (Chawla et al., 2003), show 
that the induction of synaptic activity was enough to cause nuclear exports of the class 
IIa HDACs, even under oxidative stress conditions. Histone deacetylase inhibitors, while 
unspecific, have recently been shown to be neuroprotective in the context of ischemia 
(Pickell et al., 2020) through promoting prosurvival pathways in injured cells. In a similar 
concept, approaches which prevent class IIa HDAC nuclear import may prove beneficial 
in a diseased brain struggling to counteract excessive ROS levels and resulting 
morphological neuronal damages. However, this must be carefully considered given the 
complicated crosstalk between Ca2+ signalling and ROS release (Hempel & Trebak, 
2017) and thus this approach would need to be careful to not accentuate the ROS burden 
instead of aiding in its detoxification.  
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Further work is needed to understand the role and regulation of the class IIa HDACs 
under oxidative stress in the brain. Firstly, it would be appropriate to explore specifically 
how increased ROS levels may drive a nuclear import of the class IIa HDACs. 
Treatments with CaMK inhibitors are shown to induce the nuclear transport of HDAC4 
and 5 in cerebellar granule neurons (Linseman et al., 2003). Therefore, future 
approaches could include in vivo activation of the CaMKIV kinase in rat neuronal cells or 
the use of serine/threonine phosphatase inhibitors under control, DEM and paraquat 
conditions. This would reveal any changes in class IIa HDACs localisations with those 
seen in Figure 12 and 13.  
The use of a HDAC4 mutant with the oxidisable cysteines mutated (such that they could 
no longer be oxidised) may also prove useful in this investigation. Immunohistochemistry 
to identify the location of this HDAC4 mutant within the neuronal cell under physiological 
and oxidative stress states would reveal how oxidation modifications, if any, affect class 
IIa HDAC localisation. It may also be interesting to produce HDAC4/5 mutants with both 
the phosphorylation site serines, such as the 3SA HDAC4 mutant produced in Sando et 
al., 2012, along with oxidation site cysteines mutated together for use in these 
experiments. Evidence of FOXO1 interactions with both HDAC4, along with HDAC3, and 
HDAC5 have been found in different cell types (Cho et al., 2018). Once shuttled into the 
nucleus, it should be considered if the presence of the ROS species may be promoting 
HDAC4/5 binding to FOXO transcription factors as part of their mechanism within the 
oxidative stress state in the brain. Therefore, testing FOXO-HDAC4/5 binding using 
biochemical techniques such as co-immunoprecipitation would indicate any increase in 
their binding following DEM treatments.  
Finally, investigations into a calcium influx into neuronal cells in the absence of increased 
synaptic firing could be performed. HDAC5 nuclear export has been shown to be induced 
in hippocampal neurons following stimulation of calcium flux through L-type calcium 
channels (Chawla et al., 2003). Thus, comparing low DEM treatments (and therefore low 
oxidative stress conditions) with and without Ca2+ influxes could reveal if morphological 
damages to neurons could be rescued due to the cytoplasmic accumulation of the class 
IIa HDACs. If this proves successful in being neuroprotective, it may provide an exciting 
outlook for the treatment of neurodegenerative diseases in which neuronal damage is so 
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7. Appendices   
7.1. Buffers and Solutions  
Table 11. Gel and buffer components used for western blotting. 
Buffer Components 
10% SDS PAGE (Resolving gel) 
4.2 ml dH2O, 2.5 ml resolving gel buffer, 
3.3 ml acrylamide, 50 µl APS solution, 
12-15 µl TEMED 
Resolving gel buffer 375 mM Tris-HCl, 0.1% SDS; pH 8.8 
10% SDS PAGE (Stacking gel) 
3.1 ml dH2O, 1.25 ml stacking gel buffer, 
0.65 ml acrylamide, 25 µl APS solution, 
5-7 µl TEMED 
Stacking gel buffer 125 mM Tris-HCl, 0.1% SDS; pH 6.8 
1 x PBS 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 
1 x Transfer buffer 25 mM Tris, 192 mM Glycine, 20% (v/v) methanol, pH ~8.3 
 
 
7.2. Fly food preparation  
 
50 g sucrose and 25 g dried yeast were added to a clean 500 ml bottle and a small 
amount of boiled water was added and swirled in the bottle. The bottle was microwaved 
for 2-3 minutes (in 30 second intervals) and hot water was used to top up the bottle to 
500 ml which was then autoclaved. 200 ml sucrose solution was measured out and 162 
µl of either vehicle (ethanol) or DEM was pipetted in to make 5 µM treated foods. The 
solution was swirled to mix and 40 g sawdust was added and mixed until thick. A pipette 
was used to aliquot around 1 inch of the food mix into tubes and the tubes tapped on the 
workbench to remove bubbles until smooth. A cotton wool bud was pushed down into 
the tube until almost touching the wet food. The tubes were left to dry overnight at room 













Table 12. List of abbreviations and full terms. 
Abbreviation Full name 
SDS Sodium dodecyl sulfate 
TBST Tris buffered saline, 0.1% Tween-20  
PBS Phosphate buffered saline 
APS Ammonium persulfate 
TEMED Tetramethylethylenediamine 
BSA Bovine Serum Albumin 
EDTA Ethylenediamine tetraacetic acid 
SGG CO2 dependent salt glucose glycine 
MEM Minimal essential medium 
HEPES N-2-hydroxyethylpiperazine-N-ethanesulfonic acid 
DTT Dithiothreitol 
PMSF Phenylmethylsulfonyl fluoride 
LDS Lithium dodecyl sulfate 
PVDF Polyvinylidene fluoride 
ECL Enhanced chemiluminescence 
NP-40 Nonyl phenoxypolyethoxylethanol 
PFA Paraformaldehyde  
DEPC Diethylpyrocarbonate 
TAE Tris acetate EDTA 
TM Transfection medium 
 
 
